Библиография

Часть I

Глава 1

1. AmericanCancerSociety.“CancerFactsandFigures—1998.”Atlanta,GA:

AmericanCancerSociety,1998.

2. FlegalK.M.,CarrollM.D.,OgdenC.L.etal.“Prevalenceandtrendsinobesity

amongU.S.adults,1999–2000.”JAMA288(2002):1723–1727.

3. NationalCenterforHealthStatistics.“Obesitystillontherise,newdata

show.TheU.S.DepartmentofHealthandHumanServicesNewsRelease.”

October10,2003.Washington,DC:2002.Accessedatwww.cdc.gov/nchs/

releases/02news/obesityonrise.htm

4. LinB-H.,GuthrieJ.andFrazaoE.“NutrientContributionofFoodAway

fromHome.”In:E.Frazao(ed.),America’s Eating Habits: Changes and

Consequences.Washington,DC:EconomicResearchService,USDA,1999.

Citedonp.138in:InformationPlus.Nutrition: a key to good health.Wylie,

TX:InformationPlus,1999.

5. MokdadA.H.,FordE.S.,BowmanB.A.etal.“DiabetestrendsintheU.S.:

1990–1998.”Diabetes Care23(2000):1278–1283.

6. CentersforDiseaseControlandPrevention.“NationalDiabetesFactSheet:

NationalEstimatesandGeneralInformationonDiabetesintheUnitedStates,

RevisedEdition.”Atlanta,GA:CentersforDiseaseControlandPrevention,

1998.

7. AmericanDiabetesAssociation.“Economicconsequencesofdiabetes

mellitusintheU.S.in1997.”Diabetes Care21(1998):296–309.Cited

In:MokdadA.H,FordE.S.,BowmanB.A.etal.“Diabetestrendsinthe

U.S.:1990–1998.”Diabetes Care23(2000):1278–1283.

8. AmericanHeartAssociation.“HeartDiseaseandStrokeStatistics—

2003Update.”Dallas,TX:AmericanHeartAssociation,2002.

9. OrnishD.,BrownS.E.,ScherwitzL.W.etal.“Canlifestylechangesreverse

coronaryheartdisease?”Lancet336(1990):129–133.

10. EsselstynC.B.,EllisS.G.,MedendorpS.V.etal.“Astrategytoarrestand

reversecoronaryarterydisease:a5-yearlongitudinalstudyofasinglephysi-

cian’spractice.”J. Family Practice 41(1995):560–568.

11. StarfieldB.“IsU.S.healthreallythebestintheworld?”JAMA 284(2000):

483–485.

12. AndersonR.N.“Deaths:leadingcausesfor2000.”National Vital Statistics

Reports 50(16)(2002).

13. PhillipsD.,ChristenfeldN.andGlynnL.“IncreaseinU.S.medication-error

deathbetween1983and1993.”Lancet 351(1998):643–644.

14. U.S.CongressionalHouseSubcommitteeOversightInvestigation.“Costand

qualityofhealthcare:unnecessarysurgery.”Washington,DC:1976.Cited

by:Leape,L.“Unnecessarysurgery.”Ann. Rev. Publ. Health 13(1992):

363–383.

15. LazarouJ.,PomeranzB.andCoreyP.N.“Incidenceofadversedrugreactions

inhospitalizedpatients.”JAMA 279(1998):1200–1205.

16. WorldHealthOrganization.TechnicalReportSeriesNo.425.“International

DrugMonitoring:theRoleoftheHospital.”Geneva,Switzerland:WorldHealth

Organization,1966.

17. HealthInsuranceAssociationofAmerica.Source Book of Health Insurance

Data: 1999–2000. Washington,DC,1999.

18. NationalCenterforHealthStatistics.Health, United States, 2000 with

Adolescent Health Chartbook. Hyattsville,MD:NationalCenterforHealth

Statistics,2000.

19. StarfieldB.Primary Care: Balancing Health Needs, Services, and Techno­

logy. NewYork,NY:OxfordUniversityPress,1998.

20. WorldHealthOrganization.WorldHealthReport2000:Pressrelease.“World

HealthOrganizationassessestheworld’shealthsystems.”June21,2000.

Geneva.Accessedatwww.who.int

21. CobleY.D.AmericanMedicalAssociationpressrelease.“AMAdecriesrise

innumberofuninsuredAmericans.”September30,2003.Chicago,IL.

Accessedatwww.ama-assn.org/ama/pub/article/1617–8064.html

22. CampbellT.C.“Presentdayknowledgeonaflatoxin.”Phil / Nutr 20(1967):

193–201.

23. CampbellT.C,CaedoJ.P.,Jr.,Bulatao-JaymeJ.etal.“AflatoxinM1inhuman

urine.”Nature 227 (1970):403–404.

24. ЭтапрограммавыполняласьсовместносМинистерствомздравоохране-

нияФилиппинифинансироваласьАгентствомСШАпомеждународному

развитию(USAID).

25. HuJ.,ZhaoX.,JiaJ.etal.“Dietarycalciumandbonedensityamong

middle-agedandelderlywomeninChina.”Am. J. Clin. Nutr. 58(1993):

219–227.

26. HuJ.,ZhaoX.,ParpiaB.etal.“Dietaryintakesandurinaryexcretionof

calciumandacids:across-sectionalstudyofwomeninChina.”Am. J. Clin.

Nutr. 58(1993):398–406.

27. HuJ.,ZhaoX.,ParpiaB.etal.“Assessmentofamodifiedhouseholdfood

weighingmethodinastudyofbonehealthinChina.”European J. Clin. Nutr.

48(1994):442–452.

28. PotischmanN.,McCullochC.E,ByersT.etal.“Breastcanceranddietary

andplasmaconcentrationsofcarotenoidsandvitaminA.”Am. J. Clin.

Nutr. 52(1990):909–915.

29. PotischmanN.,McCullochC.E,ByersT.etal.“Associationsbetweenbreast

cancer,triglyceridesandcholesterol.”Nutr.Cancer 15(1991):205–215.

30. ChenJ.,CampbellT.C.,LiJ.etal.Diet, life­style and mortality in China.

A study of the character istics of 65 Chinese counties. Oxford,UK;Ithaca,

NY;Beijing,PRC:OxfordUniversityPress;CornellUniversityPress;People’s

MedicalPublishingHouse,1990.

31. CampbellT.C.andChenJ.“Dietandchronicdegenerativediseasesperspec-

tivesfromChina.”Am. J. Clin. Nutr. 59(Suppl)(1994):1153S–1161S.

32. CampbellT.C.“Thedietarycausesofdegenerativediseases:nutrientsvsfoods.”

In: N.J.TempleandD.P.Burkitt(eds.),Western diseases: their dietary

prevention and reversibility, pp.119–152.Totowa,N.J.:HumanaPress,1994.

33. CampbellT.C.andChenJ.“Dietandchronicdegenerativediseases:asummary

ofresults fromanecologicstudyinruralChina.” In: N.J.Templeand

D.P.Burkitt(eds.),Western dis eases: their dietary prevention and

reversibility, pp.67–118.Totowa,N.J.:HumanaPress,1994.

34. ChittendenR.H.Physiological economy in nutrition. NewYork:F.A.Stokes,

1904.

35. ChittendenR.H.The nutrition of man. NewYork:F.A.Stokes,1907.

Глава 2

1. StillingsB.R.“Worldsuppliesofanimalprotein.”In:J.W.G.Porterand

B.A.Rolls(eds.),Proteins in Human Nutrition,pp.11–33.London:Aca-

demicPress,1973.

2. CampbellT.C.,WarnerR.G.andLoosliJ.K.“Ureaandbiuretforruminants.”

In:CornellNutritionConference,Buffalo,NY,1960,pp.96–103.

3. CampbellT.C.,LoosliJ.K.,WarnerR.G.etal.“Utilizationofbiuretby

ruminants.”J. Animal Science 22(1963):139–145.

4. AutretM.“Worldproteinsuppliesandneeds.ProceedingsoftheSixteenth

EasterSchoolinAgriculturalScience,UniversityofNottingham,1969.”

In:R.A.Laurie(ed.),Proteins in Human Food,pp.3–19.Westport,CT:

AviPublishingCompany,1970.5. ScrimshawN.S.andYoungV.R.“Nutritionalevaluationandtheutilizationof

proteinresources.”In:C.E.Bodwell(ed.),Evaluation of Proteins for Humans,pp.1–10.Westport,CT:TheAviPublishingCo.,1976.

6. JalilM.E.andTahirW.M.“Worldsuppliesofplantproteins.”In:J.WG.Porter

andB.A.Rolls(eds.),Proteins in Human Nutrition,pp.35–46.London:

AcademicPress,1973.

7. BlountW.R.“Turkey“X”Disease.”Turkeys9(1961):52,55–58,61,77.

8. SargeantK.,SheridanA,O’KellyJ.etal.“Toxicityassociatedwithcertain

samplesofgroundnuts.”Nature192(1961):1096–1097.

9. LancasterM.C.,JenkinsF.P.andPhilpJ.M.“Toxicityassociatedwithcertain

samplesofgroundnuts.”Nature192(1961):1095–1096.

10. WoganG.N.andNewberneP.M.“Dose-responsecharacteristicsofaflatoxin

B1carcinogenesisintherat.”Cancer Res. 27(1967):2370–2376.

11. WoganG.N.,PaglialungaS.andNewberneP.M.“Carcinogeniceffectsof

lowdietarylevelsofaflatoxinB1inrats.”Food Cosmet. Toxicol.12(1974):

681–685.

12. CampbellT.C.,CaedoJ.P.,Jr.,Bulatao-JaymeJ.etal.“AflatoxinM1in

humanurine.”Nature227(1970):403–404.

13. MadhavanT.V.andGopalanC.“Theeffectofdietaryproteinoncarcinoge-

nesisofaflatoxin.”Arch. Path.85(1968):133–137.

Глава 3

1. NaturalResourcesDefenseCouncil.“Intolerablerisk:pesticidesinour

children’sfood.”NewYork:NaturalResourcesDefenseCouncil,February

27,1989.

2. WinterC.,CraigmillA.andStimmannM.“FoodSafetyIssuesII.NRDC

reportandAlar.”UC Davis Environmental Toxicology Newsletter9(2)

(1989):1.

3. LiebermanA.J.andKwonS.C.“Factversusfears:areviewofthegreatest

unfoundedhealthscaresofrecenttimes.”NewYork:AmericanCouncilon

ScienceandHealth,June,1998.

4. WhelanE.M.andStareF.J.Panic in the pantry: facts andfallacies about

the food you buy. Buffalo,NY:PrometheusBooks,1992.

5. U.S.AppleAssociation.“News release:synopsisofU.S.ApplePress

Conference.”McLean,VA:U.S.AppleAssociation,February25,1999.6. CassensR.G.Nitrite­cured meat: a food safety issue in perspective.Trum-

bull,CT:FoodandNutritionPress,Inc.,1990.7. LijinskyW.andEpsteinS.S.“Nitrosaminesasenvironmentalcarcinogens.”

Nature225(1970):21–23.8. NationalToxicologyProgram.“Ninthreportoncarcinogens,revisedJanuary

2001.”Washington,DC:U.S.DepartmentofHealthandHumanServices,PublicHealthService,January2001.Accessedatehis.niehs.nih.gov/roc/toc9.html#viewe

9. InternationalAgency forCancerResearch. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Some N­Nitroso Compounds.Vol.17Lyon,France:InternationalAgencyforResearchonCancer,1978.

10. DruckreyH.,JanzowskiR.andPreussmannR.“Organotropecarcinogenewirkungenbei65verschiedenenN-nitroso-verbindungenanBD-ratten.”Z. Krebsforsch. 69(1967):103–201.

11. ThomasC.andSoB.T.“ZurmorphologiederdurchN-nitroso-verbindungenerzeugtentumorenimoberenverdauungstraktderratte.”Arzneimittdforsch.19(1969):1077–1091.

12. EisenbrandG.,SpiegelhalderB.,JanzowskiC.etal.“Volatileandnon-volatileN-nitrosocompoundsinfoodsandotherenvironmentalmedia.”IARC Sci. Publi.19(1978):311–324.

13. NationalArchivesandRecordsAdministration.“CodeofFederalRegula-tions:Title9,AnimalsandAnimalProducts,Section319.180(9CFR319.180).”Washington,DC:GovernmentPrintingOffice,2001.

14. KanferS.October2,1972.“ThedeclineandfalloftheAmericanhotdog.”Time:86.

15. NewberneP.“Nitritepromotes lymphoma incidence in rats.”Science204(1979):1079–1081.

16. MadhavanT.V.andGopalanC.“Theeffectofdietaryproteinoncarcinogenesisofaflatoxin.”Arch. Path.85(1968):133–137.

17. Еслиданныйдефектбудетиметьместонапервомэтапеформированиядочернихклеток,тозатемонраспространитсянапоследующиепоколенияклеток,приэтомпотенциальноонвконечномитогеможетбытьобнаруженввидеклиническиидентифицируемогорака.Однакоэтокрайнеупрощен-ноеописаниечрезвычайносложногопроцесса.Возможно,дванаиболеесущественныхмомента,неучтенныхвданномописании,–этогипотезыотом,что:1)дляинициацииипромоцииракаможетпотребоватьсяболееодноймутации,и2)невсегенетическиесбоиприводятквозникновениюрака.

18. MgbodileMUKandCampbellT.C.“Effectofproteindeprivationofmaleweanling ratson thekineticsofhepaticmicrosomalenzymeactivity.”J. Nutr.102(1972):53–60.

19. HayesJ.R.,MgbodileM.U.K.andCampbellT.C.“Effectofproteindeficiencyontheinducibilityofthehepaticmicrosomaldrug-metabolizingenzymesystem.I.EffectonsubstrateinteractionwithcytochromeP-450.”Biochem. Pharmacol.22(1973):1005–1014.

20. MgbodileM.U.K.,HayesJ.R.andCampbellT.C.“Effectofproteindeficiencyontheinducibilityofthehepaticmicrosomaldrug-metabolizingenzymesystem.II.Effectonenzymekineticsandelectrontransportsystem.”Biochem. Pharmacol.22(1973):1125–1132.

21. HayesJ.R.andCampbellT.C.“Effectofproteindeficiencyontheinducibilityofthehepaticmicrosomaldrug-metabolizingenzymesystem.III.Effectof3-methylcholanthreneinductiononactivityandbindingkinetics.”Biochem. Pharmacol.23(1974):1721–1732.

22. CampbellT.C.“Influenceofnutritiononmetabolismofcarcinogens(MarthaMasoHonor’sThesis).”Adv. Nutr. Res.2(1979):29–55.

23. PrestonR.S.,HayesJ.R.andCampbellT.C.“TheeffectofproteindeficiencyontheinvivobindingofaflatoxinB

1torat livermacromolecules.”Life

Sci.19(1976):1191–1198.

24. PortmanR.S.,PlowmanK.M.andCampbellT.C.“Onmechanisms

affectingspeciessusceptibilitytoaflatoxin.”Biochim. Biophys. Acta208

(1970):487–495.

25. PrinceL.O.andCampbellT.C.“EffectsofsexdifferenceanddietaryproteinlevelonthebindingofaflatoxinB1toratliverchromatinproteinsinvivo.”Cancer Res.42(1982):5053–5059.

26. MainigiK.D.andCampbellT.C.“Subcellulardistributionandcovalentbindingofaflatoxinsasfunctionsofdietarymanipulation.”J Toxicol. Eviron. Health6(1980):659–671.

27. NerurkarL.S.,HayesJ.R.andCampbellT.C.“Thereconstitutionofhepa-ticmicrosomalmixedfunctionoxidaseactivitywithfractionsderivedfromweanlingratsfeddifferentlevelsofprotein.”J. Nutr.108(1978):678–686.

28. GurtooH.L.andCampbellT.C.“Akineticapproachtoastudyoftheinductionofratlivermicrosomalhydroxylaseafterpretreatmentwith3,4-benzpyreneandaflatoxinB

1”Biochem. Pharmacol.19(1970):1729–1735.29. AdekunleA.A.,HayesJ.R.andCampbellT.C.“Interrelationshipsofdietary

proteinlevel,aflatoxinB1metabolism,andhepaticmicrosomalepoxidehydrase

activity.”Life Sci.21(1977):1785–1792.30. MainigiK.D.andCampbellT.C.“Effectsoflowdietaryproteinanddietary

aflatoxinonhepaticglutathionelevelsinF-344rats.”Toxicol Appl. Phar­macol59(1981):196–203.

31. FarberE.andCameronR.“Thesequentialanalysisofcancerdevelopment.”Adv. Cancer Res. 31(1980):125–226.

32. Реакцияочаговнаразличныхграфикахвэтойглавевосновномотражает«%отобъемапечени»,которыйобъединяет«количествоочагов»и«раз-мерочагов»–обаэтихпоказателяпоказываюттенденциюформированияопухоли.Длятогочтобыреакцииочаговвразличныхэкспериментахможнобылосравниватьдругсдругом,данныеприведенывсоответствиесединойшкалой,котораяотражаетреакциюврезультатевоздействиястандартнойдозыафлатоксинаприсодержаниибелковвпитании,равном20%.

33. AppletonB.S.andCampbellT.C.“Inhibitionofaflatoxin-initiatedpreneo-plasticliverlesionsbylowdietaryprotein.”Nutr. Cancel(1982):200–206.

34. DunaifG.E.andCampbellT.C.“RelativecontributionofdietaryproteinlevelandAflatoxinB

1doseingenerationofpresumptivepreneoplasticfociinratliver.”J. Natl. Cancer Inst.78(1987):365–369.

35. YoungmanL.D.andCampbellT.C.“Highproteinintakepromotesthegrowthofpreneoplastic foci inFischer#344rats:evidencethatearlyremodeledfociretainthepotentialforfuturegrowth.”J. Nutr.121(1991):1454–1461.

36. YoungmanL.D.andCampbellT.C.“InhibitionofaflatoxinBlindu-cedgamma-glutamyl transpeptidasepositive (GGT+)hepaticpre-neoplasticfociandtumorsbylowproteindiets:evidencethatalteredGGT+fociindicateneoplasticpotential.”Carcinogenesis13(1992):1607–1613.

37. DunaifG.E.andCampbellT.C.“DietaryproteinlevelandaflatoxinB1-

inducedpreneoplastichepatic lesionsintherat.”J. Nutr.117(1987):1298–1302.

38. HorioF.,YoungmanL.D.,BellR.C.etal.“Thermogenesis,low-proteindiets,anddecreaseddevelopmentofAFBl-inducedpreneoplasticfociinratliver.”Nutr. Cancer 16(1991):31–41.

39. СогласноНациональномусоветупоисследованиямприНациональнойакадемиинаук,длямаксимизациискоростиростаорганизманеобходимо,чтобыдолябелковвпищебыларавна12%.

40. SubcommitteeonLaboratoryAnimalNutrition.Nutrient requirements of laboratory animals. Second revised edition, number 10.Washington,DC:NationalAcademyPress,1972.

41. NationalResearchCouncil.Recommended dietary allowances. Tenth edition.Washington,DC:NationalAcademyPress,1989.

42. SchulsingerD.A.,RootM.M.andCampbellT.C.“EffectofdietaryproteinqualityondevelopmentofaflatoxinB

1-inducedhepaticpreneoplasticlesions.”J. Natl. Cancer Inst.81(1989):1241–1245.

43. YoungmanL.D.The growth and development of aflatoxin B1­induced

preneoplastic lesions, tumors, metastasis, and spontaneous tumors as they are influenced by dietary protein level, type, and intervention.Ithaca,NY:CornellUniversity,Ph.D.Thesis,1990.

44. BeasleyR.P.“HepatitisBvirusastheetiologicagentinhepatocellular

carcinoma-epidemiologicconsiderations.”Hepatol.2(1982):21S–26S.

45. BlumbergB.S.,LarouzeB.,LondonW.T.etal.“TherelationofinfectionwiththehepatitisBagenttoprimaryhepaticcarcinoma.”Am.]. Pathol.81(1975):669–682.

46. ChisariF.V.,FerrariC.andMondelliM.U.“HepatitisBvirusstructureandbiology.”Microbiol. Pathol. 6(1989):311–325.

47. HuJ.,ChengZ.,ChisariF.V.etal.“RepressionofhepatitisBvirus(HBV)transgeneandHBV-inducedliverinjurybylowproteindiet.”Oncogene 15(1997):2795–2801.

48. ChengZ.,HuJ.,KingJ.etal.“InhibitionofhepatocellularcarcinomadevelopmentinhepatitisBvirustransfectedmicebylowdietarycasein.”Hepatology 26(1997):1351–1354.

49. HawrylewiczE.J.,HuangH.H.,KissaneJ.Q.etal.“Enhancementofthe7,12-dimethylbenz(a)anthracene(DMBA)mammarytumorigenesisbyhighdietaryproteininrats.”Nutr. Reps. Int.26(1982):793–806.

50. HawrylewiczE.J.“Fat-proteininteraction,denned2-generationstudies.”In: C.Ip,D.EBirt.A.E.RogersandC.Mettlin(eds.),Dietary fat and cancer,pp.403–434.NewYork:AlanR.Liss,Inc.,1986.

51. HuangH.H.,HawrylewiczE.J.,KissaneJ.Q.etal.“Effectofproteindietonreleaseofprolactinandovariansteroidsinfemalerats.”Nutr. Rpts. Int.26(1982):807–820.

52. O’ConnorT.P.,RoebuckB.D.andCampbellT.C.“Dietaryinterventionduringthepost-dosingphaseofL-azaserine-inducedpreneoplasticlesions.”NatlCancer Inst 75(1985):955–957.

53. O’ConnorT.P.,RoebuckB.D.,PetersonF.etal.“EffectofdietaryintakeoffishoilandfishproteinonthedevelopmentofL-azaserine-inducedpreneoplasticlesionsinratpancreas.”J Natl Cancer Inst 75(1985):959–962.

54. HeY.Effects of carotenoids and dietary carotenoid extracts on aflatoxin B

1­induced mutagenesis and hepatocarcinogenesis.Ithaca,NY:Cornell

University,PhDThesis,1990.55. HeY.andCampbellT.C.“EffectsofcarotenoidsonaflatoxinB

1-inducedmutagenesisinS.typhimuriumTA100andTA98.”Nutr. Cancer13(1990):

243–253.

Глава 4

1. LiJ-Y.,LiuB-Q.,LiG-Y.etal.“AtlasofcancermortalityinthePeople’s

RepublicofChina.Anaidforcancercontrolandresearch.”Int. J. Epid.

10(1981):127–133.

2. HigginsonJ.“Presenttrendsincancerepidemiology.”Proc. Can. Cancer

Conf.8(1969):40–75.

3. WynderE.L.andGoriG.B.“Contributionoftheenvironmenttocancerinci-

dence:anepidemiologicexercise.”J. Natl. Cancer Inst.58(1977):825–832.

4. DollR.andPetoR.“Thecausesofcancer:Quantitativeestimatesofavoidable

risksofcancerintheUnitesStatestoday.”JNatlCancerInst66(1981):

1192–1265.

5. Fagin D. News release. “Breast cancer cause still elusive study: no

clear link between pollution, breast cancer on LI.” August 6, 2002.

Newsday.com.Accessedatwww.newsday.com/news/local/longisland/

ny-licanc062811887aug06.story?coll=ny%2Dtop%2Dheadlines

6. Имелисьданныепо82заболеваниям,приводящимксмерти,нооколо

третиэтихслучаевбылиповторениемоднойитойжеболезниулюдей

различноговозраста.

7. УпотреблениекалорийвКитаеприведенодлямужчинывесом65кг,за-

нимающегося«легкимфизическимтрудом».Приведенныедлясравнения

данныедляамериканскогомужчиныскорректированыдлявесатела,

равного65кг.

8. SerVaasC.“DietsthatprotectedagainstcancersinChina.”The Saturday

Evening PostOctober1990:26–28.

9. Всеимеющиесяданныепосмертностиотзаболеванийбылисведены

вматрицу,чтобыможнобылолегкосопоставитьпоказательпокаждой

изболезнейспоказателемполюбойдругой.Послекаждогосопоставле-

нияполученномупоказателюприсваивалсязнак«плюс»или«минус»,

взависимостиоттого,наблюдаласьлимеждунимипрямаяилиобратная

взаимосвязь.Всеслучаипрямойкорреляциибыливключеныводин

список,авсеслучаиотрицательнойкорреляции–вдругой.Укаждой

болезнивкаждомизэтихдвухсписковимелась,такимобразом,прямая

зависимостьсболезнямиизэтогожесписка,нообратнаязависимость

сболезнямиизпротивоположногосписка.Большаячасть(хотяиневсе)

изэтихпоказателейкорреляциибылистатистическизначимыми.

10. CampbellT.C.,ChenJ.,BrunT.etal.“China:fromdiseasesofpovertyto

diseasesofaffluence.Policyimplicationsoftheepidemiologicaltransition.”

Ecol. Food Nutr.27(1992):133–144.

11. ChenJ.,CampbellT.C.,LiJ.etal.Diet, life­style and mortality in China.

Astudyofthecharacteristicsof65Chinesecounties.Oxford,UK;Ithaca,

NY;Beijing,PRC:OxfordUniversityPress;CornellUniversityPress;People’s

MedicalPublishingHouse,1990.

12. LipidResearchClinicsProgramEpidemiologyCommittee.“Plasmalipid

distributionsinselectedNorthAmericanPopulation.TheLipidResearch

ClinicsProgramPrevalenceStudy.”Circulation60(1979):427–439.

13. CampbellT.C.,ParpiaB.,andChenJ.“Diet,lifestyle,andtheetiologyof

coronaryarterydisease:TheCornellChinaStudy.”Am. J. Cardiol.82(1998):

18T–21T.

14. ЭтоданныедлядеревеньSA,LCиRAдляженщиниSA,QCиNBдля

мужчин,какпоказановмонографии(Ченидр.1990).

15. SirtoriC.R.,NosedaG.andDescovichG.C.“Studiesontheuseofasoybean

proteindietforthemanagementofhumanhyperlipoproteinemias.”In:M.J.

GibneyandD.Kritchevsky(eds.),Current Topics in Nutrition and Disease,

Volume 8: Animal and Vegetable Proteins in Lipid Metabolism and

Atherosclerosis.,pp.135–148.NewYork,NY:AlanR.Liss,Inc.,1983.

16. CarrollK.K.“Dietaryproteinsandaminoacids—theireffectsoncholesterol

metabolism.”In:M.J.GibneyandD.Kritchevsky(eds.),Animaland

VegetableProteins in Lipid Metabolism and Atherosclerosis,pp.9–17.

NewYork,NY:AlanR.Liss,Inc.,1983.

17. TerpstraA.H.M.,HermusR.J.J.andWestC.E.“Dietaryproteinand

cholesterolmetabolism in rabbitsandrats.” In:M.J.GibneyandD.

Kritchevsky(eds.),Animal and Vegetable Proteins in Lipid Metabolism

and Athersclerosis,pp.19–49.NewYork:AlanR.Liss,Inc.,1983.

18. KritchevskyD.,TepperS.A,CzarneckiS.K.etal.“Atherogenicityof

animalandvegetableprotein.Influenceofthelysinetoarginineratio.”

Atherosclerosis41(1982):429–431.

19. Употреблениепищевыхжировможетбытьвыраженокакдоляотобщего

весаупотребляемойпищиилиотобщегоколичестваупотребляемыхкало-

рий.Большинствоспециалистовиисследователейговорятобупотреблении

жировкакдолиотобщегоколичествакалорий,посколькумыпитаемся

преждевсегодлятого,чтобыудовлетворитьсвоюпотребностьвкалориях,

аневвесе.Вкнигеяпользуюсьименноэтимметодом.

20. NationalResearchCouncil.Diet, Nutrition and Cancer.Washington,DC:

NationalAcademyPress,1982.

21. UnitedStatesDepartmentofHealthandHumanServices.The Surgeon

General’s Report on Nutrition and Health.Washington,DC:Superintendant

ofDocuments,U.S.GovernmentPrintingOffice,1988.

22. NationalResearchCouncilandCommitteeonDietandHealth.Diet and

health: implications for reducing chronic disease risk.Washington,DC:

NationalAcademyPress,1989.

23. ExpertPanel.Food, nutrition and the prevention of cancer, a global

perspective.Washington,DC:AmericanInstituteforCancerResearch/World

CancerResearchFund,1997.

24. Средиисключений–пища,искусственнолишеннаяжира,такаякакобез-

жиренноемолоко.

25. ArmstrongD.andDollR.“Environmentalfactorsandcancerincidenceand

mortalityindifferentcountries,withspecialreferencetodietarypractices.”Int.

]. Cancer 15(1975):617–631.

26. U.S.Senate.“DietarygoalsfortheUnitedStates,2ndEdition.”Washington,

DC:U.S.GovernmentPrintingOffice,1977.

27. CommitteeonDietNutritionandCancer.Diet, nutrition and cancer: direc­

tions for research. Washington,DC:NationalAcademyPress,1983.

28. Вэтовремясуществовалиимногиедругиеполитическиепрограммы

имасштабныеисследованиялюдей,широкообсуждавшиесявобществе,

которыебылиорганизованыилиинтерпретированывсвязисвопросом

овзаимосвязимеждуупотреблениемвпищужировивозникновением

заболеваний.Срединихпубликациясериидокладов«Рекомендации

поправильномупитаниювСША»(U.S.DietaryGuidelines)в1980г.,

запусквГарварде«Исследованияздоровьямедсестер»в1984г.,первые

отчетыопроведении«Фрамингемскогоисследованиясердца»в1960г.,

«Исследованиесемистран»АнселяКиса,«Интервенционноеисследо-

ваниемножественныхфакторовриска»(MultipleRiskFactorIntervention

Trial,MRFIT)идр.29. CarrollK.K.,BradenL.M.,BellJ.A.etal.“Fatandcancer.”Cancer58(1986):

1818–1825.30. DrasarB.S.andIrvingD.“Environmentalfactorsandcancerofthecolonand

breast.”Br. ]. Cancer 27(1973):167–172.31. HaenszelW.andKuriharaM.“StudiesofJapaneseMigrants:mortalityfrom

cancerandotherdiseaseamongjapaneseandtheUnitedStates.”J Natl CancerInst40(1968):43–68.

32. HigginsonJ.andMuirC.S.“EpidemiologyinCancer.”In:J.F.HollandandE.Frei(eds.),Cancer Medicine,pp.241–306.Philadelphia,PA:LeaandFebiger,1973.

33. Корреляциямеждуприемомвпищужировиживотныхбелковсоставляет84%прирассмотренииупотребленияжироввграммахи70%какдолиотупотребляемыхкалорий.

34. KelseyJ.L.,GammonM.D.andEstherM.J.“Reproductivefactorsandbreastcancer.”Epidemiol. Revs.15(1993):36–47.

35. deStavolaB.L.,WangD.Y.,AllenD.S.etal.“Theassociationofheight,weight,menstrualandreproductiveeventswithbreastcancer:resultsfromtwoprospectivestudiesontheislandofGuernsey(UnitedKingdom).”Cancer Causes and Control4(1993):331–340.

36. RautalahtlM.,AlbanesD.,VirtamoJ.etal.“Lifetimemenstrualactivity—indicatorofbreastcancerrisk.”(1993):17–25.

37. Невозможнобылообнаружитьстатистическизначимуюкорреляциюмеждууровнемгормоноввкровиирискомвозникновенияракамолочнойжелезыуэтойгруппыженщин,посколькузаборанализовкровиунихпроизводилсявразличныеднименструальногоциклаичастотазаболеваемостиракоммолочнойжелезыбылакрайненизкой,такимобразом,возможностьвы-явлениятакойкорреляции,дажевслучаееесуществования,быласведенакминимуму.

38. KeyTJA,ChenJ.,WangD.Y.etal.“SexhormonesinwomeninruralChinaandinBritain.”Brit. J. Cancer62(1990):631–636.

39. Этоследующиебиомаркеры:уровеньмедивплазме,азотмочевиныкрови,эстрадиол,пролактин,тестостерони(обратнаязависимость)половойгор-мон,связывающийглобулин,длякаждогоизкоторыхпосредствомболеераннихисследованийбылоустановленоналичиекорреляциисприемомвпищуживотныхбелков.

40. ДляупотребленияпищевойклетчаткивцеломсредниепоказателидляКитаяиСШАсоставляли33,3и11,1гвдень,соответственно.ДиапазонколебаниясреднегозначенияпоокругамвКитаесоставляет7,7–77,6гвденьпосравнениюс2,4–26,6гвденьвсреднемдля90%американскихмужчин.

41. Корреляциядлярастительныхбелковсоставляла+0,53***,адляживот-ныхбелков+0,12.

42. Использование«преобладаниязаболеванияракомсредичленовсемьи»дляизмерениярезультатапозволяетболееэффективноконтролироватьразличныепричинывозникновениярака,которыекоррелируютсраз-личнымиразновидностямирака,чтопозволяет,такимобразом,изучитьизолированноевлияниефакторапитания.

43. GuoW.,LiJ.,BlotW.J.etal.“CorrelationsofdietaryintakeandbloodnutrientlevelswithesophagealcancermortalityinChina.”Nutr. Cancer13(1990):121–127.

44. Полностьювлияниеэтихжирорастворимыхантиоксидантовможетбытьпродемонстрированолишьтогда,когдаконцентрацияантиоксидантовкорректируетсясучетомуровнялипопротеиданизкойплотности(LDL)длякаждогоотдельногоучастникаисследования.Этонебылоизвестно

намоментпроведенияисследования,поэтомутакаякорректировканебылапредусмотрена.

45. KnellerR.W.,GuoW.,HsingA.W.etal.“Riskfactorsforstomachcancerinsixty-fiveChinesecounties.”Cancer Epi. Biomarkers Prev.1(1992):113–118.

46. InformationPlus.Nutrition: a key to good health.Wylie,TX:InformationPlus,1999.

47. WestmanE.C.,YancyW.S.,EdmanJ.S.etal.“CarbohydrateDietProgram.”Am. ]. Med.113(2002):30–36.

48. AtkinsR.C.Dr. Atkins’ New Diet Revolution.NewYork,NY:AvonBooks,1999.

49. WrightJ.D.,Kennedy-StephensonJ.,WangC.Y.etal.“TrendsinIntakeofEnergyandMacronutrients—UnitedStates,1971–2000.”Morbidity and mortality weekly report 53(February6,2004):80–82.

50. NoakesM.andCliftonP.M.“Weightlossandplasmalipids.”Curr. Opin. Lipidol. 11(2000):65–70.

51. BilsboroughS.A.andCroweT.C.“Low-carbohydratediets:whatarethepotentialshort-andlong-termhealthimplications?”Asia Vac. J. Clin. Nutr.12(2003):396–404.

52. StevensA.,RobinsonD.P.,TurpinJ.etal.“Suddencardiacdeathofanado-lescentduringdieting.”South. Med. J.95(2002):1047–1049.

53. PattyA.“Low-carbfadclaimsteen’slife—Stardietblamedindeath.”

The Daily Telegraph (Sidney, Australia) November2,2002:10.

54. Atkins,1999.Page275.

55. Аткинсутверждал,чтококтейльизантиоксидантовможетзащититьот

сердечно-сосудистыхионкологическихзаболеванийистарения.Данное

заявлениебылоопровергнутонесколькимикрупнымиисследованиями

(см.главу11).

56. Atkins,1999.Page103.

57. BoneJ.“DietdoctorAtkins’obese’,hadheartproblems:coroner:Widowangrily

deniesthatopponents’claimsthatheartconditioncausedbycontroverialdiet.”

Ottawa CitizenFebruary11,2004:A11.

58. CampbellT.C.“Energybalance:interpretationofdatafromruralChina.”

Toxicological Sciences52(1999):87–94.

59. HorioF.,YoungmanL.D.,BellR.C.etal.“Thermogenesis,low-proteindiets,

anddecreaseddevelopmentofAFBl-inducedpreneoplasticfociinratliver.”

Nutr. Cancer16(1991):31–41.

60. KriegerE.,YoungmanL.D.andCampbellT.C.“Themodulationofaflatoxin

(AFB1)inducedpreneoplasticlesionsbydietaryproteinandvoluntaryexercise

inFischer344rats.”FASEB J.2(1988):3304Abs.

61. Цитируемыеданныеокорреляциидляприемаживотныхирастительных

белковвзятыизрукописи,находившейсянарецензировании.

62. CampbellT.C.,ChenJ.,LiuC.etal.“Non-associationofaflatoxinwithprimary

livercancerinacross-sectionalecologicsurveyinthePeople’sRepublicof

China.”Cancer Res.50(1990):6882–6893.

Часть IIГлава 5

1. AdamsC.E.“Howmanytimesdoesyourheartbeatperyear?”Accessed

October20,2003.Accessedatwww.straightdope.com/classics/al_088a.html2. NationalHeart,LungandBloodInstitute.“MorbidityandMortality:2002

ChartBookonCardiovascular,Lung,andBloodDiseases.”Bethesda,MD:NationalInstitutesofHealth,2002.

3. AmericanHeartAssociation.“HeartDiseaseandStrokeStatistics—2003Update.”Dallas,TX:AmericanHeartAssociation,2002.

4. Braunwald E. “Shattuck lecture-cardiovascular medicine at the turnof themillenium:triumphs,concernsandopportunities.”New Engl.]. Med.337(1997):1360–1369.

5. AmericanCancerSociety.“CancerFactsandFigures—1998.”Atlanta,GA:AmericanCancerSociety,1998.

6. AndersonR.N.“Deaths:leadingcausesfor2000.”National Vital Statistics Reports 50(16)(2002).

7. EnosW.E.,HolmesR.H.andBeyerJ.“CoronarydiseaseamongUnitedStatessoldierskilledinactioninKorea.”JAMA152(1953):1090–1093.

8. EsselstynC.J.“Resolvingthecoronaryarterydiseaseepidemicthroughplant-

basednutrition.”Prev. Cardiol.4(2001):171–177.

9. AntmanE.M.andBraunwaldE.“Acutemyocardialinfarction.”In:E.Braun-

wald(ed.),Heart disease, a textbook of cardiovascular disease,Vol.II

(FifthEdition),pp.1184–1288.Philadelphia:WB.SaundersCompany,1997.

10. EsselstynC.J.“Lecture:Reversingheartdisease.”December5,2002.Ithaca,

NY:CornellUniversity,2002.

11. AmbroseJ.A.andFusterV.“Canwepredictfutureacutecoronaryeventsin

patientswithstablecoronaryarterydisease?”JAMA277(1997):343–344.

12. ForresterJ.S.andShahP.K.“Lipidloweringversusrevascularization:anidea

whosetime(fortesting)hascome.”Circulation96(1997):1360–1362.

13. NownamedtheNationalHeart,Lung,andBloodInstituteoftheNational

InstitutesofHealthinBethesda,Maryland.

14. GofmanJ.W.,LindgrenF.,ElliotH.etal.“Theroleoflipidsandlipoproteins

inatherosclerosis.”Science111(1950):166.

15. KannelW.B.,DawberT.R.,KaganA.etal.“Factorsofriskinthedevelopment

ofcoronaryheartdisease—six-yearfollow-upexperience.”Ann. Internal

Medi.55(1961):33–50.

16. JolliffeN.,andArcherM.“Statisticalassociationsbetweeninternational

coronaryheartdiseasedeathratesandcertainenvironmental factors.”

J. Chronic Dis.9(1959):636–652.

17. ScrimgeourE.M.,McCallM.G.,SmithD.E.,etal.“Levelsolserumcholes-

terol,triglyceride,HDLcholesterol,apolipoproteinsA-landB,andplasma

glucose,andprevalenceoldiastolichypertensionandcigarettesmokingin

PapuaNewGuineaHighlanders.”Pathology21(1989):46–50.

18. CampbellT.C.,ParpiaB.andChenJ.“Diet,lifestyle,andtheetiologyof

coronaryarterydisease:TheCornellChinaStudy.”Am. J. Cardiol.82(1998):

18T–21T.

19. KaganA.,HarrisB.R.,WinkelsteinW.etal.“Epidemiologicstudiesofcoro-

naryheartdiseaseandstrokeinJapanesemenlivinginJapan,Hawaiiand

California.”J. Chronic Dis.27(1974):345–364.

20. KatoH.,TillotsonJ.,NichamanM.Z.,etal.“Epidemiologicstudiesof

coronaryheartdiseaseandstrokeinJapanesemenlivinginJapan,Hawaii

andCalifornia:serumlipidsanddiet.”Am.]. Epidemiol 97(1973):372–385.

21. MorrisonL.M.“Arteriosclerosis.”JAMA145(1951):1232–1236.

22. MorrisonL.M.“Diet incoronaryatherosclerosis.”JAMA173(1960):

884–888.

23. LyonT.P.,YankleyA.,GolmanJ.W.,etal.“Lipoproteinsanddietincoronary

heartdisease.”California Med.84(1956):325–328.

24. GibneyM.J.,andKritchevskyD.,eds.Current Topics in Nutrition and

Disease, Volume 8: Animal and Vegetable Proteins in Lipid Metabolism

and Atherosclerosis.NewYork,NY:AlanR.Liss,Inc.,1983.

25. SirtoriC.R.,NosedaG.,andDescovichG.C.“Studiesontheuseolasoybean

proteindiet forthemanagementolhumanhyperlipoproteinemias.” In:

M.J.GibneyandD.Kritchevsky(eds.),CurrentTopicsinNutritionand

Disease,Volume8:AnimalandVegetableProteinsinLipidMetabolism

andAtherosclerosis.,pp.135–148.NewYork,NY:AlanR.Liss,Inc.,1983.

26. G.S.Myers,personalcommunication,citedbyGroom,D.“Populationstudies

olatherosclerosis.”Ann. Internal Med.55(1961):51–62.

27. CentersforDiseaseControl.“SmokingandHealth:anationalstatusreport.”

Morbidity and Mortality Weekly Report35(1986):709–711.

28. CentersforDiseaseControl.“Cigarettesmokingamongadults—United

States,2000.”Morbidity and Mortality Weekly Report51(2002):642–645.

29. Age-adjusted,pages25–74.

30. MarwickC.“Coronarybypassgraftingeconomics,includingrehabilitation.

Commentary.”Curr. Opin. Cardiol.9(1994):635–640.

31. Page1319inGershB.J.,BraunwaldE.andRutherfordJ.D.“Chronic

coronaryarterydisease.”In:E.Braunwald(ed.),HeartDisease:ATextbookof

cardiovascularMedicine,Vol.2(FifthEdition),pp.1289–1365.Philadelphia,

PA:W.B.Saunders,1997.

32. OrnishD.“Avoidingrevascularizationwithlifestylechanges:theMulticenter

LifestyleDemonstrationProject.”Am. J. Cardiol.82(1998):72T-76T

33. ShawP.J.,BatesD.,CartlidgeN.E.F.etal.“Earlyintellectualdyslunction

followingcoronarybypasssurgery.”Quarterly]. Med.58(1986):59–68.

34. CameronA.A.C.,DavisK.B.,andRogersW.J.“Recurrenceolanginaafter

coronaryarterybypasssurgery.Predictorsandprognosis(CASSregistry).”

J. Am. Coll. Cardiol.26(1995):895–899.

35. Page1320inGershB.J.,BraunwaldE.andRutherfordJ.D.“Chronic

coronaryarterydisease.”In: E.Braunwald(ed.),HeartDisease:ATextbookof

cardiovascularMedicine,Vol.2(FifthEdition),pp.1289–1365.Philadelphia,

PA:W.B.Saunders,1997.

36. KirklinJ.W.,NaftelD.C.,BlackstoneE.H.etal.“Summaryolaconsensus

concerningdeathandischemiceventsaftercoronaryarterybypassgrafting.”

Circulation79(Suppl1)(1989):181–191.

37. Page1368–9inLincoffA.M.andTopolE.J.“Interventionalcatherization

techniques.”In:E.Braunwald(ed.),HeartDisease:ATextbookofCardio-

vascularMedicine,pp.1366–1391.Philadelphia,PA:W.B.Saunders,1997.

38. HirshfeldJ.W.,SchwartzJ.S.,JugoR.etal.“Restenosisaftercoronary

angioplasty:amultivariatestatisticalmodeltorelatelesionandprocedure

variablestorestenosis.”J. Am. Coll. Cardiol.18(1991):647–656.

39. InformationPlus.Nutrition: a key to good health.Wylie,TX:Information

Plus,1999.40. NaifehS.W.The Best Doctors in America, 1994–1995.Aiken,S.C.:Wood-

ward&White,1994.41. EsselstynC.B.,Jr.“Foreward:changingthetreatmentparadigmforcoronary

arterydisease.”Am. J. Cardiol.82(1998):2T–4T.42. EsselstynC.B.,EllisS.G.,MedendorpS.V.,etal.“Astrategytoarrestand

reversecoronaryarterydisease:a5-yearlongitudinalstudyofasinglephysician’spractice.”J. Family Practice41(1995):560–568.

43. EsselstynC.J.“Introduction:morethancoronaryarterydisease.”Am. J. Cardiol.82(1998):5T–9T.

44. Кровотоксоответствуетчетвертойстепенирадиуса.Такимобразом,уменьшениена7%приблизительносоответствуетувеличениюкровотока

на30%,хотяневозможнопутемрасчетовопределитьданныйпоказательболееточно.

45. PersonalcommunicationwithDr.Esselstyn,9/15/03.46. OrnishD.,BrownS.E.,ScherwitzL.W.,etal.“Canlifestylechangesreverse

coronaryheartdisease?”Lancet336(1990):129–133.47. RatliffN.B.“Ofrice,grain,andzeal: lessonsfromDrs.Kempnerand

Esselstyn.”Cleveland Clin. J. Med.67(2000):565–566.48. AmericanHeartAssociation.“AHADietaryGuidelines.Revision2000:

AStatementforHealthcareProfessionalsfromtheNutritionCommitteeoftheAmericanHeartAssociation.”Circulation 102(2000):2296–2311.

49. NationalCholesterolEducationProgram.“ThirdreportoftheNationalCholesterol Education Program (NCEP) expert panel on detection,evaluationandtreatmentofhighbloodcholesterolinadult(adulttreatmentpanelIII):executivesummary.”Bethesda,MD:National InstitutesofHealth,2001.

50. CastelliW.“Takethislettertoyourdoctor.”Prevention48(1996):61–64.51. SchulerG.,HambrechtR.,SchlierfG.,etal.“Regularphysicalexerciseand

low-fatdiet.”Circulation86(1992):1–11.

Глава 6

1. FlegalK.M.,CarrollM.D.,OgdenC.L.etal.“Prevalenceandtrendsin

obesityamongU.S.adults,1999–2000.”JAMA288(2002):1723–1727.

2. OgdenC.L.,FlegalK.M.,CarrollM.D.etal.“Prevalenceandtrendsin

overweightamongU.S.childrenandadolescents.”JAMA288(2002):1728–

1732.

3. DietzW.H.“Healthconsequencesofobesityinyouth:childhoodpredictorsof

adultdisease.” Pediatrics101(1998):518–525.

4. FontaineK.R.,andBarofskyI.“Obesityandhealth-relatedqualityoflife.”

Obesity Rev.2(2001):173–182.

5. ColditzG.A.“Economiccostsofobesityandinactivity.”Med. Sci. Sports

Exerc.31(1999):S663–S667.

6. AdcoxS.“Newstatelawseekstocutdownobesity.”Ithaca Journal Sept.21,

2002:5A.

7. EllisF.R.andMontegriffoV.M.E.“Veganism,clinicalfindingsandinvestiga-

tions.”Am. J. Clin. Nutr.23(1970):249–255.

8. BerensonG.,SrinivasanS.,BaoW.,NewmanW.P.R.,TracyR.E.,and

WattigneyW.A.“Associationbetweenmultiplecardiovascularriskfactorsand

atherosclerosistochildrenandyoungadults.TheBogalusaHeartStudy.”New

Engl. J. Med.,338:1650–1656,1998.

9. KeyT.J.,FraserG.E.,ThorogoodM.etal.“Mortality invegetarians

andnonvegetarians:detailed findings fromacollaborativeanalysisof

5prospectivestudies.”Am. J. Clin. Nutri.70(Suppl)(1999):516S–524S.

10. BerganJ.G.andBrownP.T.“Nutritionalstatusof“new”vegetarians.”J. Am.

Diet. Assoc.76(1980):151–155.

11. ApplebyP.N.,ThorogoodM.,MannJ.etal.“Lowbodymassindexinnon-

meateaters:thepossiblerolesofanimalfat,dietaryfibre,andalcohol.”Int

J. Obes.22(1998):454–460.

12. DwyerJ.T.“Healthaspectsofvegetariandiets.”Am.]. Clin. Nutr.48(1988):

712–738.

13. KeyT.J.andDaveyG.“Prevalenceofobesityislowinpeoplewhodonoteat

meat.”Brit. Med. Journ.313(1996):816–817.

14. ShintaniT.T.,HughesC.K.,BeckhamS.etal.“Obesityandcardiovascular

riskinterventionthroughtheadlibitumfeedingoftraditionalHawaiiandiet.”

Am. J. Clin. Nutr.53(1991):1647S–1651S.15. BarnardR.J.“Effectsoflife-stylemodificationonserumlipids.”Arch. Intern.

Med. 151(1991):1389–1394.16. McDougallJ.,LitzauK.,HaverE.etal.“Rapidreductionofserumcholesterol

andbloodpressurebyatwelve-dayverylowfat,strictlyvegetariandiet.”J. Am. Coll. Nutr.14(1995):491–496.

17. OrnishD.,ScherwitzL.W.,DoodyR.S.etal.“Effectsofstressmanagementtraining and dietary changes in treating ischemic heart disease.”JAMA249(1983):54–59.

18. ShintaniT.T.,BeckhamS.,BrownA.C.etal.“TheHawaiidiet:adlibitum

highcarbohydrate,lowfatmulti-culturaldietforthereductionofchronic

diseaserisk factors:obesity,hypertension,hypercholesterolemia,and

hyperglycemia.”Hawaii Med. Journ.60(2001):69–73.

19. NicholsonA.S.,SklarM.,BarnardN.D.etal.“Towardimprovedmanagement

ofNIDDM:arandomized,controlled,pilotinterventionusingalowfat,

vegetariandiet.”Prev. Med.29(1999):87–91.

20. OrnishD.,ScherwitzL.W.,BillingsJ.H.etal.“Intensivelifestylechangesfor

reversalofcoronaryheartdisease.”JAMA 280(1998):2001–2007.

21. AstrupA.,ToubroS.,RabenA.etal.“Theroleoflow-fatdietsandfatsubstitutes

inbodyweightmanagement:whathavewelearnedfromclinicalstudies?”

J. Am. Diet. Assoc. 97(Suppl)(1997):S82–S87.

22. DuncanK.H.,BaconJ.A.andWeinsierR.L.“Theeffectsofhighandlow

energydensitydietsonsatiety,energyintake,andeatingtimeofobeseand

nonobesesubjects.”Am. J. Clin. Nutr.37(1983):763–767.

23. HeatonK.W.“Foodfibreasanobstacletoenergyintake.”Lancet(1973):

1418–1421.

24. LevinN.,RattanJ.andGilatT.“Energyintakeandbodyweightinovo-lacto

vegetarians.”J. Clin. Gastroenterol.8(1986):451–453.

25. CampbellT.C.“Energybalance:interpretationofdatafromruralChina.”

Toxicological Sciences52(1999):87–94.

26. PoehlmanE.T.,ArcieroP.J.,MelbyC.L.etal.“Restingmetabolicrateand

postprandialthermogenesisinvegetariansandnonvegetarians.”Am. J.

Clin. Nutr.48(1988):209–213.

27. Исследование,проведенноеПоэльманомидр.,показаловысокийуровень

поглощениякислородаиболеевысокуюскоростьобменавеществвсо-

стояниипокоя,ноэтирезультатыбылиневерноистолкованыавторами.

Мыполучилиоченьпохожиерезультатывходеопытовнакрысах.

28. FogelholmM.andKukkonen-HarjulaK.“Doesphysicalactivityprevent

weightgain—asystematicreview.”Obesity Rev.1(2000):95–111.

29. RavussinE.,LilliojaS.,AndersonT.E.etal.“Determinantsof24-hourenergy

expenditureinman.Methodsandresultsusingarespiratorychamber.”J. Clin.

Invest.78(1986):1568–1578.

30. ThorburnA.W.andProiettoJ.“Biologicaldeterminantsofspontaneousphysical

activity.”Obesity Rev.1(2000):87–94.

31. KriegerE.,YoungmanL.D.andCampbellT.C.“Themodulationofaflatoxin

(AFBl)inducedpreneoplasticlesionsbydietaryproteinandvoluntaryexercise

inFischer344rats.”FASEB J.2(1988):3304Abs.

32. HeshkaS.andAllisonD.B.“Isobesityadisease?”Int. J. Obesity Rel.

Dis.25(2001):1401–1404.

33. KopelmanP.G.andFinerN.“Reply:isobesityadisease?” Int J. Obes.25

(2001):1405–1406.

34. CampbellT.C.“Areyourgeneshazardoustoyourhealth?”Nutrition Advo­

cate 1(1995):1–2,8.

35. CampbellT.C.“Geneticseedsofdisease.Howtobeattheodds.”Nutrition

Advocate1(1995):1–2,8.

36. CampbellT.C.“The’FatGene’dreammachine.”Nutrition Advocate 2(1996):

1–2.

Глава 71. MokdadA.H.,FordE.S.,BowmanB.A.etal.“DiabetestrendsintheU.S.:

1990–1998.”Diabetes Care 23(2000):1278–1283.

2. CentersforDiseaseControlandPrevention.“NationalDiabetesFactSheet:

GeneralInformationandNationalEstimatesonDiabetesintheUnitedStates,

2000.”Atlanta,GA:CentersforDiseaseControlandPrevention.

3. GriffinK.L.“Newlifestyles:newlifestyles,hopeforkidswithdiabetes.”

Milwaukee Journal Sentinel22July2002:1G.

4. AmericanDiabetesAssociation.“Type2diabetesinchildrenandadolescents.”

Diabetes Care 23(2000):381–389.

5. HimsworthH.P.“Dietandtheincidenceofdiabetesmellitus.”Clin. Sci.2

(1935):117–148.

6. WestK.M.andKalbfleischJ.M.“Glucosetolerance,nutrition,anddiabetesin

Uruguay,Venezuela,Malaya,andEastPakistan.”Diabetes15(1966):9–18.

7. WestK.M.andKalbfleischJ.M.“Influenceofnutritionalfactorsonprevalence

ofdiabetes.”Diabetes 20(1971):99–108.

8. FraserG.E.“Associationsbetweendietandcancer,ischemicheartdisease,and

all-causemortalityinnon-HispanicwhiteCaliforniaSeventh-dayAdventists.”

Am. ]. Clin. Nutr. 70(Suppl)(1999):532S–538S.

9. SnowdonD.A.andPhillipsR.L.“Doesavegetariandietreducetheoccurrence

ofdiabetes?”Am.]. Publ. Health75(1985):507–512.

10. TsuneharaC.H.,LeonettiD.L.andFujimotoW.Y.“Dietofsecondgeneration

Japanese-Americanmenwithandwithoutnon-insulin-dependentdiabetes.”

Am. ]. Clin. Nutri.52(1990):731–738.

11. MarshallJ.,HammanR.F.andBaxterJ.“High-fat,low-carbohydratedietand

theetiologyofnon-insulin-dependentdiabetesmellitus:theSanLuisValley

Study.”Am.J. Epidemiol.134(1991):590–603.

12. KittagawaT.,OwadaM.,UrakamiT.etal.“Increasedincidenceofnon-insulin-

dependentdiabetesmellitusamongJapaneseschoolchildrencorrelateswithan

increasedintakeofanimalproteinandfat.”Clin. Pediatr.37(1998):111–116.

13. TrowellH.“Diabetesmellitusdeath-ratesinEnglandandWales1920–

1970andfoodsupplies.”Lancet2(1974):998–1002.

14. MeyerK.A.,KushiL.H.,JacobsD.R.,Jr.etal.“Carbohydrates,dietaryfiber,

andincidentType2diabetesinolderwomen.”Am. J. Clin. Nutri.71(2000):

921–930.

15. AndersonJ.W.“Dietaryfiberinnutritionmanagementofdiabetes.”In:

G.VahounyVandD.Kritchevsky(eds.),Dietary Fiber: Basic and Clinical

Aspects,pp.343–360.NewYork:PlenumPress,1986.

16. AndersonJ.W.,ChenW.L.andSielingB.“Hypolipidemiceffectsofhigh-

carbohydrate,highfiberdiets.”Metabolism 29(1980):551–558.

17. StoryL.,AndersonJ.W.,ChenW.L.etal.“Adherencetohigh-carbohydrate,

high-fiberdiets:long-termstudiesofnon-obesediabeticmen.”Journ. Am.

Diet. Assoc. 85(1985):1105–1110.

18. BarnardR.J.,LattimoreL.,HollyR.G.etal.“Responseofnon-insulin-

dependentdiabeticpatientstoanintensiveprogramofdietandexercise.”

Diabetes Care 5(1982):370–374.

19. BarnardR.J.,MasseyM.R.,ChernyS.etal.“Long-termuseofahigh-

complex-carbohydrate,high-fiber,low-fatdietandexerciseinthetreatmentof

NIDDMpatients.”Diabetes Care6(1983):268–273.

20. AndersonJ.W.,GustafsonN.J.,BryantC.A.etal.“Dietaryfiberanddiabetes:

acomprehensivereviewandpracticalapplication.”J. Am. Diet. Assoc.87

(1987):1189–1197.

21. JenkinsD.J.A,WoleverT.M.S,BaconS.etal.“Diabeticdiets:high

carbohydratecombinedwithhighfiber.”Am. J. Clin. Nutri.33(1980):

1729–1733.

22. DiabetesPreventionProgramResearchGroup.“Reductionintheincidence

ofType2diabeteswithlifestyleinterventionorMetformin.”New Engl. J.

Med.346(2002):393–403.

23. TuomilehtoJ.,LindstromJ.,ErikssonJ.G.etal.“PreventionofType2

diabetesmellitusbychangesinlifestyleamongsubjectswithimpairedglu-

cosetolerance.”New Engl. J. Med.344(2001):1343–1350.

Глава 8

1. Эстроген,присутствующийвсвоейсвободной,несвязаннойформе.

2. Активностьэстрогенаобусловленаразличнымиегоразновидностями,но

обычносвязанасэстрадиолом.Ябудуиспользоватьобщийтермин«эстро-

ген»,объединяющийвсестероидыисвязанныеснимиженскиегормоны,

влияниекоторыхсоответствуетвоздействиюэстрадиола.Небольшое

количествотестостеронаворганизмеженщиноказываетаналогичное

воздействие.

3. WuA.H.,PikeM.C.andStramD.O.“Meta-analysis:dietaryfatintake,

serumestrogenlevels,andtheriskofbreastcancer.”J. Nat. Cancer Inst.

91(1999):529–534.

4. BernsteinL.andRossR.K.“Endogenoushormonesandbreastcancerrisk.”Epidemiol. Revs.15(1993):48–65.

5. PikeM.C.,SpicerD.V.,DahmoushL.etal.“Estrogens,progestogens,normalbreastcellproliferation,andbreastcancerrisk.”Epidemiol. Revs.15(1993):17–35.

6. BocchinfusoW.P.,LindzeyJ.K.,HewittS.C.etal.“Inductionofmammaryglanddevelopmentinestrogenreceptor-alphaknockoutmice.”Endocrino­logy 141(2000):2982–2994.

7. AtwoodC.S.,HoveyR.C.,GloverJ.P.etal.“Progesteroneinducesside-branchingoftheductalepitheliuminthemammaryglandsofperipubertalmice.”J. Endocrinol.167(2000):39–52.

8. RoseD.P.,andPruittB.T.“Plasmaprolactinlevelsinpatientswithbreastcancer.”Cancer48(1981):2687–2691.

9. DorganJ.F.,LongcopeC,.StephensonH.E.Jr.etal.“Relationofprediag-nosticserumestrogenandandrogenlevelstobreastcancerrisk.”Cancer Epidemiol Biomarkers Prey 5(1996):533–539.

10. DorganJ.F.,StanczykF.Z.,LongcopeC.etal.“Relationshipofserumdehydroepiandrosterone(DHEA),DHEAsulfate,and5-androstene-3beta,17beta-dioltoriskofbreastcancerinpostmenopausalwomen.”Cancer Epidemiol Biomarkers Prev 6(1997).

11. ThomasH.V.,KeyT.J.,AllenD.S.etal.“Aprospectivestudyofendogenousserumhormoneconcentrationsandbreastcancerriskinpost-menopausalwomenontheislandofGuernsey.”Brit.J. Cancer 76(1997):410–405.

12. HankinsonS.E.,WillettW.,MansonJ.E.etal.“Plasmasexsteroidhormonelevelsandriskofbreastcancerinpostmenopausalwomen.”J. Nat. Cancer Inst.90(1998):1292–1299.

13. RosenthalM.B.,BarnardR.J.,RoseD.P.etal.“Effectsofahigh-complex-carbohydrate,low-fat, low-cholesteroldietonlevelsofserumlipidsandestradiol.”Am. J. Med. 78(1985):23–27.

14. AdlercreutzH.“WesterndietandWesterndiseases:somehormonalandbiochemicalmechanismsandassociations.”Scand. J. Clin. Lab. Invest.

50(Suppl201)(1990):3–23.

15. HeberD.,AshleyJ.M.,LeafD.A.etal.“Reductionofserumestradiolin

postmenopausalwomengivenfreeaccesstolow-fathigh-carbohydratediet.”

Nutrition 7(1991):137–139.

16. RoseD.P.,GoldmanM.,ConnollyJ.M.etal.“High-fiberdietreducesserum

estrogenconcentrationsinpremenopausalwomen.”Am.]. Clin. Nutr.54

(1991):520–525.

17. RoseD.P.,LubinM.andConnollyJ.M.“Efectsofdietsupplementationwith

wheatbranonserumestrogenlevelsinthefollicularandlutealphasesofthe

menstrualcycle.”Nutrition 13(1997):535–539.

18. TymchukC.N.,TesslerS.B.andBarnardR.J.“Changesinsexhormone-

bindingglobulin,insulin,andserumlipidsinpostmenopausalwomenonalow-

fat,high-fiberdietcombinedwithexercise.”Nutr. Cancer38(2000):158–162.

19. KeyT.J.A,ChenJ.,WangD.Y.etal.“SexhormonesinwomeninruralChina

andinBritain.”Brit.]. Cancer62(1990):631–636.

20. PrenticeR.,ThompsonD.,CliffordC.etal.“Dietaryfatreductionandplasma

estradiolconcentrationinhealthypostmenopausalwomen.”J. Natl. Cancer

lnst. 82(1990):129–134.

21. BoyarA.P.,RoseD.P.andWynderE.L.“Recommendationsfortheprevention

ofchronicdisease:theapplicationforbreastdisease.”Am. J. Clin. Nutr.48

(3Suppl)(1988):896–900.

22. NandiS.,GuzmanR.C.andYangJ.“Hormonesandmammarycarcinoge-

nesisinmice,ratsandhumans:aunifyinghypothesis.”Proc. National Acad.

Sci92(1995):3650–3657.

23. PetoJ.,EastonD.F.,MatthewsF.E.etal.“Cancermortalityinrelatives

ofwomenwithbreastcancer,theOPCSstudy.”Int. J. Cancer65(1996):

275–283.

24. ColditzG.A.,WillettW.,HunterD.J.etal.“Familyhistory,age,andrisk

ofbreastcancer.ProspectivedatafromtheNurses’HealthStudy.”JAMA

270(1993):338–343.

25. NationalHumanGenomeResearchInstitute.“LearningAboutBreast

Cancer.”Accessedatwww.genome.gOv/l0000507#ql

26. FutrealP.A.,LiuQ.,Shattuck-EidensD.etal.“BRCA1mutationsinprimary

breastandovariancarcinomas.”Science266(1994):120–122.

27. MikiY.,SwensenJ.,Shatttuck-EidensD.etal.“Astrongcandidateforthe

breastandovariancancersusceptibilitygeneBRCA1.” Science 266(1994):

66–71.

28. WoosterR.,BignellG.,LancasterJ.etal.“Identificationofthebreastcancer

susceptibilitygeneBRCA2.”Nature378(1995):789–792.

29. TavtigianS.V.,SimardJ.,RommensJ.etal.“ThecompleteBRCA2gene

andmutationsinchromosome13q-linkedkindreds.”Nat. Genet.12(1996):

333–337.

30. FordD.,EastonD.,BishopD.P.etal.“RisksofcancerinBRCA1mutation

carriers.”Lancet 343(1994):692–695.

31. AntoniouA.,PharoahP.D.P,NarodS.etal.“Averagerisksofbreastandovarian

cancerassociatedwithBRCA1orBRCA2mutationsdetectedincaseseries

unselectedforfamilyhistory:acombinedanalysisof22studies.”Am. J. Hum.

Genet.72(2003):1117–1130.

32. NewmanB.,MuH.,ButlerL.M.etal.“Frequencyofbreastcancer

attributabletoBRCA1inapopulation-basedseriesofAmericanwomen.”

JAMA 279(1998):915–921.

33. PetoJ.,CollinsN.,BarfootR.etal.“PrevalenceofBRCA1andBRCA2gene

mutationsinpatientswithearly-onsetbreastcancer.”J. Nat. Cancer lnst.91

(1999):943–949.

34. TabarL.,FagerbergG.,ChenH.H.etal.“Efficacyofbreastcancerscreening

byage.NewresultsfromtheSwedishTwo-CountyTrial.”Cancer75(1995):

2507–2517.

35. BjurstramN.,BjorneldL.,DuffyS.W.etal.“TheGothenburgBreastCancer

ScreeningTrial:firstresultsonmortality,incidence,andmodeofdetectionfor

womenages39–49yearsatrandomization.”Cancer80(1997):2091–2099.

36. FrisellJ.,LidbrinkE.,HellstromL.etal.“Follow-upafter11years:update

ofmortalityresultsintheStockholmmammographicscreeningtrial.”Breast

Cancer Res. Treat 199745(1997):263–270.

37. GreenleeR.T.,Hill-HarmonM.B.,MurrayT.etal.“Cancerstatistics,2001.”

CA Cancer]. Clin. 51(2001):15–36.

38. CairnsJ.“ThetreatmentofdiseasesandtheWaragainstCancer.”Sci. Am.

253(1985):31–39.

39. CuzickJ.andBaumM.“Tamoxifenandcontralateralbreastcancer.”Lancet2

(1985):282.

40. CuzickJ.,WangD.Y.andBulbrookR.D.“Thepreventionofbreastcancer.”

Lancet1(1986):83–86.

41. FisherB.,CostantinoJ.P.,WickerhamD.L.etal.“Tamoxifenforprevention

ofbreastcancer:reportoftheNationalSurgicalAdjuvantBreastandBowel

ProjectP-lStudy.”J. Nat. Cancer Inst. 90(1998):1371–1388.

42. FreedmanA.N.,GraubardB.I.,RaoS.R.etal.“Estimatesofthenumber

ofU.S.women who could benefit from tamoxifen for breast cancer

chemoprevention.”J. Nat. Cancer Inst.95(2003):526–532.

43. PowlesT.,EelesR.,AshleyS.etal.“Interimanalysisoftheincidence

ofbreastcancer intheRoyalMarsdenHospital tamoxifenrandomised

chemopreventiontrial.”Lancet 352(1998):98–101.

44. VeronesiU.,MaisonneuveP.,CostaA.etal.“Preventionofbreastcancer

withtamoxifen:preliminaryfindingsfromtheItalianrandomisedtrialamong

hysterectomisedwomen.”Lancet 352(1998):93–97.

45. CuzickJ.“Abriefreviewofthecurrentbreastcancerpreventiontrialsand

proposalsforfuturetrials.”Eur J Cancer 36(2000):1298–1302.

46. CummingsS.R.,EckertS.,KruegerK.A.etal.“Theeffectofraloxifeneonrisk

ofbreastcancerinpostmenopausalwomen:resultsfromtheMORErandomized

trial.”JAMA281(1999):2189–2197.

47. DorganJ.F.,HunsbergerS.A.,McMahonR.P.etal.“Dietandsex

hormonesingirls: findingsfromarandomizedcontrolledclinicaltrial.”

J. Nat. Cancer Inst. 95(2003):132–141.

48. OrnishD.,ScherwitzL.W.,BillingsJ.H.etal.“Intensivelifestylechangesfor

reversalofcoronaryheartdisease.”JAMA280(1998):2001–2007.

49. EsselstynC.B.,EllisS.G.,MedendorpS.V.etal.“Astrategytoarrest

andreversecoronaryarterydisease:a5-yearlongitudinalstudyofasingle

physician’spractice.” J. Family Practice 41(1995):560–568.

50. HildenbrandG.L.G,HildenbrandL.C.,BradfordK.etal.“Five-yearsurvivalrates

ofmelanomapatientstreatedbydiettherapyafterthemannerofGerson:aretro-

spectivereview.”Alternative Therapies in Health and Medicine1(1995):29–37.

51. YoungmanL.D.andCampbellT.C.“InhibitionofaflatoxinBl-inducedgamma-

glutamyltranspeptidasepositive(GGT+)hepaticpreneoplasticfociandtumors

bylowproteindiets:evidencethatalteredGGT+fociindicateneoplastic

potential.”Carcinogenesis 13(1992):1607–1613.

52. RonaiZ.,GradiaS.,El-BayoumyK.etal.“Contrastingincidenceofras

mutationsinratmammaryandmouseskintumorsinducedbyanti-benzo[c]

phenanthrene-3,4-diol-l,2-epoxide.” Cardnogensis 15(1994):2113–2116.

53. JeffyB.D.,SchultzE.U.,SelminO.etal.“InhibitionofBRCA-1expressionby

benzo[a]pyreneanddiolepoxide.”Mol. Carcinogenesis 26(1999):100–118.

54. GammonM.D.,SantellaR.M.,NeugutAl.etal.“Environmentaltoxins

andbreastcanceronLongIsland.I.PolycyclicaromatichydrocarbonDNA

adducts.”Cancer Epidemiol Biomarkers Prey11(2002):677–685.

55. GammonM.D.,WolffM.S.,NeugutAl.etal.“Environmentaltoxinsand

breastcanceronLongIsland.II.Organchlorinecompoundlevelsinblood.”

Cancer Epidemiol Biomarkers Prey11(2002):686–697.

56. HumphriesK.H.andGillS.“Risksandbenefitsofhormonereplacement

therapy:theevidencespeaks.”Canadian Med. Assoc. Journ.168(2003):

1001–1010.

57. WritingGroupfortheWomen’sHealthInitiativeInvestigators.“Risksand

benefitsofestrogenplusprogestln inhealthypostmenopausalwomen:

principalresultsfromtheWomen’sHealthInitiativeRandomizedControlled

Trial.”JAMA 288(2002):321–333.

58. Hulley S., Grady D., Bush T. et al. “Randomized trial of estrogen

plusprogestin for secondarypreventionofcoronaryheartdisease in

postmenopausalwomen.HeartandEstrogen/progestinReplacement

Study(HERS)ResearchGroup.”JAMA280(1998):605–613.

59. Whilethisfindingisnotstatisticallysignificant,itsconsistencywiththeWHI

findingisstriking.

60. InternationalAgencyforCancerResearch.“Globocan”(accessed18October

2002),www-dep.iarc/globocan.html.”

61. KinzlerK.W.andVogelsteinB.“LessonsfromHeredity.ColorectalCancer.”

Cell87(1996):159–170.

62. FerlayJ.,BrayF,.PisaniP.etal.GLOBOCAN 2000:Cancer Incidence,

mortality and prevalence worldwide, Version 1.0.Lyon,France:IARCPress,

2001.

63. LimitedversionofFerlayetal.documentavailableatwww.dep.iarc.fr/globocan/

globocan.htm,lastupdatedon03/02/2001.

64. ExpertPanel.Food, nutrition and the prevention of cancer, a global

perspective.Washington,DC:AmericanInstituteforCancerResearch/World

CancerResearchFund,1997.

65. ArmstrongD.andDollR.“Environmentalfactorsandcancerincidenceand

mortalityindifferentcountries,withspecialreferencetodietarypractices.”Int.

J. Cancer 15(1975):617–631.

66. BurkittD.P.“Epidemiologyofcancerofthecolonandtherectum.”Cancer28

(1971):3–13.

67. JansenMCJF,Bueno-de-MesquitaH.B,BuzinaR.etal.“Dietaryfiberand

plantfoodsinrelationtocolorectalcancermortality:TheSevenCountries

Study.”Int. J. Cancer81(1999):174–179.

68. WhiteleyL.O.andKlurfeldD.M.“Aredietaryfiber-inducedalterationsin

colonicepithelialcellproliferationpredictiveoffiber’seffectoncoloncancer?”

Nutr. Cancer 36(2000):131–149.

69. Вбольшинствесвоемэтипоказателикорреляциинеявлялисьстати-

стическизначимыми,однакостабильностьобнаружениякорреляции

междуупотреблениемклетчаткиивозникновениемколоректального

ракавпечатляла.

70. CampbellT.C.,WangG.,ChenJ.etal.“Dietaryfiberintakeandcolon

cancermortalityinThePeople’sRepublicofChina.”In:D.KritchevskyC.

BonfieldandJ.WAnderson(eds.),Dietary Fiber,pp.473–480.NewYork,

NY:PlenumPublishingCorporation,1990.

71. TrockB.,LanzaE.andGreenwaldP.“Dietaryfiber,vegetables,andcolon

cancer:criticalreviewandmeta-analysisoftheepidemiologicevidence.”J. Nat.

Cancer Inst.82(1990):650–661.

72. HoweG.R.,BenitoE.,CastelletoR.etal.“Dietaryintakeoffiberanddecreased

riskofcancersofthecolonandrectum:evidencefromthecombinedanalysis

of13case-controlstudies.”J. Nat. Cancer Inst. 84(1992):1887–1896.

73. BinghamS.A.,DayN.E.,LubenR.etal.“Dietaryfibreinfoodandprotection

againstcolorectalcancerintheEuropeanProspectiveInvestigationinto

CancerandNutrition(EPIC):anobservationalstudy.”Lancet361(2003):

1496–1501.

74. O’KeefeS.J.D,NdabaN.andWoodwardA.“Relationshipbetweennutri-

tionalstatus,dietaryintakepatternsandplasmalipoproteinconcentra-

tionsinruralblackSouthAfricans.”Hum. Nutr. Clin. Nutr.39(1985):

335–341.

75. SitasE.“HistologicallydiagnosedcancersinSouthAfrica,1988.”S. African

Med. J.84(1994):344–348.

76. O’KeefeS.J.D.,KiddM.,Espitalier-NoelG.etal.“Rarityofcoloncancerin

Africansisassociatedwithlowanimalproductconsumption,notfiber.”Am. J.

Gastroenterology 94(1999):1373–1380.

77. McKeown-EyssenG.“Epidemiologyofcolorectalcancerrevisited:areserum

triglyceridesand/orplasmaglucoseassociatedwithrisk?”Cancer Epidemiol

Biomarkers Prev3(1994):687–695.

78. GiovannucciE.“Insulinandcoloncancer.”Cancer Causes and Control

6(1995):164–179.

79. BruceW.R,.GiaccaA.andMedlineA.“Possiblemechanismsrelatingdiet

andriskofcoloncancer.”Cancer Epidemiol Biomarkers Prev 9(2000):

1271–1279.

80. KonoS.,HonjoS.,TodorokiI.etal.“Glucoseintoleranceandadenomasof

thesigmoidcoloninJapanesemen(Japan).”Cancer Causes and Control9

(1998):441–446.

81. SchoenR.E.,TangenC.M.,KullerL.H.etal.“Increasedbloodglucose

andinsulin,bodysize,andincidentcolorectalcancer.”J. Nat. Cancer Inst.

91(1999):1147–1154.

82. BruceW.R.,WoleverT.M.S.andGiaccaA.“Mechanismslinkingdietand

colorectalcancer:thepossibleroleofinsulinresistance.”Nutr. Cancer 37

(2000):19–26.

83. LipkinM.andNewmarkH.“Developmentofclinicalchemopreventiontrials.”

J. Nat. Cancer Inst.87(1995):1275–1277.

84. HoltP.R.,AtillasoyE.O.,GilmanJ.etal.“Modulationofabnormalcolonic

epithelialcellproliferationanddifferentiationbylow-fatdairyfoods.Arando-

mizedtrial.”JAMA280(1998):1074–1079.

85. MobarhanS.“Calciumandthecolon:recentfindings.”Nutr. Revs.57(1999):

124–126.

86. AlbertsD.S.,RitenbuaghC.,StoryJ.A.etal.“Randomized,double-blinded,

placebo-controlledstudyofeffectofwheatbranfiberandcalciumonfecalbile

acidsinpatientswithresectedadenomatouscolonpolyps.“J. Nat. Cancer Inst.

88(1996):81–92.

87. ChenJ.,CampbellT.C.,LiJ.etal.Diet, life­style and mortality in China.

A study of the characteristics of 65 Chinese counties.Oxford,UK;Ithaca,

NY;Beijing,PRC:OxfordUniversityPress;CornellUniversityPress;People’s

MedicalPublishingHouse,1990.

88. JassJ.R.“Coloncancer:theshapeofthingstocome.”Gut 45(1999):

794–795.

89. BurtR.W.“Coloncancerscreening.” Gastroenterology119(2000):837–853.

90. WinawerS.J.,ZauberA.G.,HoM.N.,etal.“Preventionofcolorectal

cancerbycolonoscopicpolypectomy”New Engl. J. Med.329(1993):

1977–1981.

91. PignoneM.,RichM.,TeutschS.M.etal.“Screeningforcolorectalcancer

inadultsataveragerisk:asummaryoftheevidencefortheU.S.Preventive

ServicesTaskForce.”Ann. Internal Med.137(2002):132–141.

92. ScottR.J.andSobolH.H.“Prognosticimplicationsofcancersusceptibility

genes:Anynews?”Recent Resets in Cancer Research 151(1999):71–84.

93. LeeM.L.,WangR-T.,HsingA.W.etal.“Case-controlstudyofdietand

prostatecancerinChina.”Cancer Causes and Control 9(1998):545–552.

94. VillersA.,SoulieM.,HaillotO.etal.“Prostatecancerscreening(III):risk

factors,naturalhistory,coursewithouttreatment.”Progr. Urol.7(1997):

655–661.

95. StanfordJ.L.“Prostatecancertrends1973–1995.”Bethesda,MD:SEER

Program,NationalCancerInstitute,1998.

96. ChanJ.M.andGiovannucciE.L.“Dairyproducts,calcium,andvitamin

Dandriskofprostatecancer.”Epidemiol. Revs.23(2001):87–92.

97. GiovannucciE.“Dietaryinfluencesof1,25(OH)2vitaminDinrelation

toprostatecancer:ahypothesis.”Cancer Causes and Control9(1998):

567–582.

98. ChanJ.M.,StampferM.J.,MaJ.etal.“Insulin-likegrowthfactor-I(IGF-I)

andIGFbindingprotein-3aspredictorsofadvanced-stageprostatecancer.”

J Natl. Cancer Inst 94(2002):1099–1109.

99. DoiS.Q.,RasaiahS.,TackI.etal.“Low-proteindietsuppressesserum

insulin-likegrowthfactor-1anddeceleratestheprogresseionofgrowth

hormone-inducedglomerulosclerosis.”Am. J. Nephrol.21(2001):331–339.

100. HeaneyR.P.,McCarronD.A.,Dawson-HughesB.etal.“Dietarychanges

favorablyaffectbondremodeling inolderadults.”J. Am. Diet. Assoc.

99(1999):1228–1233.

101. AllenN.E.,ApplebyP.N.,DaveyG.K.etal.“Hormonesanddiet:lowinsulin-

likegrowthfactor-Ibutnormalbioavailableandrogensinveganmen.”Brit.].

Cancer83(2000):95–97.

102. CohenP.,PeehlD.M.andRosenfeldR.G.“TheIGFaxisintheprostate.”

Horm.. Metab. res.26(1994):81–84.

Глава 9

1. MackayI.R.“Toleranceandimmunity.”Brit. Med. Journ.321(2000):93–96.

2. JacobsonD.L.,GangeS.J.,RoseN.R.etal.“Shortanalyticalreview.

Epidemiologyandestimatedpopulationburdenofselectedautoimmune

diseasesintheUnitedStates.”Clin. Immunol. Immunopath. 84(1997):

223–243.

3. DavidsonA.,andDiamondB.“Autoimmunediseases.”New Engl. J. Med.345

(2001):340–350.

4. ArandaR.,SydoraB.C.,McAllisterP.L.etal.“Analysisofintestinallympho-

cytesinmousecolitismediatedbytransferofCD4*,CD45RBhighTcellsto

SCIDrecipients.”J. Immunol. 158(1997):3464–3473.

5. FolgarS.,GattoE.M.,RainaG.,etal.“Parkinsonismasamanifestationof

multiplesclerosis.”Movement Disorders18(2003):108–113.

6. CantornaM.X.“VitaminDandautoimmunity: isvitaminDstatusan

environmentalfactoraffectingautoimmunediseaseprevalence?”Proc. Soc.

Exp. Biol. Med.223(2000):230–233.

7. DeLucaH.F.andCantornaM.X.“VitaminD: its roleanduses in

immunology.”FASEB J.15(2001):2579–2585.

8. WinerS.,AstsaturovI.,CheungR.K.etal.“Tcellsofmultiplesclerosispatients

targetacommonenvironmentalpeptidethatcausesencephalitisinmice.”

J. Immunol. 166(2001):4751–4756.

9. DavenportC.B.“Multiplesclerosisfromthestandpointofgeographicdistri-

butionandrace.”Arch. Neurol. Pschiatry8(1922):51–58.

10. AlterM.,YamoorM.andHarsheM.“Multiplesclerosisandnutrition.”Arch.

Neurol. 31(1974):267–272.

11. CarrollM.“Innateimmunityintheetiopathologyofautoimmunity.”Nature

Immunol.2(2001):1089–1090.

12. KarjalainenJ.,MartinJ.M.,KnipM.etal.“Abovinealbuminpeptideas

apossibletriggerofinsulin-dependentDiabetesMellitus.”New Engl. Journ.

Med.327(1992):302–307.

13. AkerblomH.K.andKnipM.“PutativeenvironmentalfactorsandType1

diabetes.”Diabetes / Metabolism Revs.14(1998):31–67.

14. NaikR.G.andPalmerJ.R.“Preservationofbeta-cellfunctioninType1

diabetes.”Diabetes Rev. 7(1999):154–182.

15. VirtanenS.M.,RasanenL.,AroA.etal.“InfantfeedinginFinnishchildren

lessthan7yrofagewithnewlydiagnosedIDDM.ChildhooddiabetesinFin-

landStudyGroup.”Diabetes Care 14(1991):415–417.

16. SavilahtiE.,AkerblomH.K.,TainioV-M.etal.“Childrenwithnewlydiagnosed

insulindependentdiabetesmellitushaveincreasedlevelsofcow’smilk

antibodies.”Diabetes Res.7(1988):137–140.

17. YakotaA.,YamaguchiT.,UedaT.etal.“Comparisonofisletcellantibodies,

isletcellsurfactantibodiesandanti-bovineserumalbuminantibodiesin

Type1diabetes.”Diabetes Res. Clin. Pract.9(1990):211–217.

18. Hammond-McKibbenD.andDoschH-M.“Cow’smilk,bovineserum

albumin,andIDDM:canwesettlethecontroversies?”Diabetes Care20

(1997):897–901.

19. AkerblomH.K.,VaaralaO.,HyotyH.etal.“Environmentalfactorsinthe

etiologyofType1diabetes.”Am. J. Med. Genet.(Semin. Med. Genet.)

115(2002):18–29.

20. GottliebM.S.andRootH.E.“Diabetesmellitusintwins.”Diabetes 17

(1968):693–704.

21. BarnettA.H.,EffC.,LeslieRDG.etal.“Diabetesinidenticaltwins:astudy

of200pairs.”Diabetologia 20(1981):87–93.

22. Borch-JohnsenK.,JonerG.,Mandrup-PoulsenT.etal.“Relationbetween

breastfeedingandincidenceratesofinsulin-dependentdiabetesmellitus:

ahypothesis.”Lancet 2(1984):1083–1086.

23. Perez-BravoF.,CarrascoE.,Gutierrez-LopezM.D.etal.“Geneticpredispo-

sitionandenvironmental factorsleadingtothedevelopmentof insulin-

dependentdiabetesmellitusinChileanchildren.”J. Mol. Med.74(1996):

105–109.

24. KostrabaJ.N.,CruickshanksK.J.,Lawler-HeavnerJ.etal.“Earlyexposure

tocow’smilkandsolidfoodsininfancygeneticpredisposition,andriskof

IDDM.”Diabetes42(1993):288–295.

25. PykeD.A.“Thegeneticperspective:puttingresearchintopractice.”In:

Diabetes1988,Amsterdam,1989,pp.1227–1230.

26. KaprioJ.,TuomilehtoJ.,KoskenvuoM.etal.“ConcordanceforType1

(insulin-dependent)andType2(non-insulin-dependent)diabetesmellitus

inapopulation-basedcohortoftwinsinFinland.”Diabetologia 35(1992):

1060–1067.

27. Dahl-JorgensenK.,JonerG.andHanssenK.E.“Relationshipbetween

cow’smilkconsumptionandincidenceofIDDMinchildhood.”Diabetes Care

14(1991):1081–1083.

28. Доляслучаеввозникновениясахарногодиабетапервоготипа,обусловлен-

наяупотреблениемкоровьегомолока,тоестьпоказательr2,равна96%.

29. LaPorteR.E.,TajimaN.,AkerblomH.K.etal.“Geographicdifferencesin

theriskofinsulin-dependentdiabetesmellitus:theimportanceofregistries.”

Diabetes Care8(Suppl1)(1985):101–107.

30. BodanskyH.J.,StainesA.,StephensonC.etal.“Evidenceforanenvironmental

effect intheaetiologyof insulindependentdiabetesinatransmigratory

population.”Brit. Med. Journ.304(1992):1020–1022.31. BurdenA.C.,SamantaA.andChaunduriK.H.“Theprevalenceandincidence

ofinsulin-dependentdiabetesinwhiteandIndianchildreninLeicestercity(UK).”Int. J. Diabetes Dev. Countries10(1990):8–10.

32. ElliottR.andOngT.J.“Nutritionalgenomics.”Brit. Med. Journ.324(2002):1438–1442.

33. OnkamoP.,VaananenS.,KarvonenM.etal.“WorldwideincreaseinincidenceofType1diabetes—theanalysisofthedataonpublishedincidencetrends.”Diabetologia 42(1999):1395–1403.

34. GersteinH.C.“Cow’smilkexposureandType1diabetesmellitus:acriticaloverviewoftheclinicalliterature.”Diabetes Care17(1994):13–19.

35. KimpimakiT.,ErkkolaM.,KorhonenS.etal.“Short-termexclusivebreastfee-dingpredisposesyoungchildrenwithincreasedgeneticriskofType1diabetestoprogressivebeta-cellautoimmunity”Diabetologia44(2001):63–69.

36. VirtanenS.M.,LaaraE.,HypponenE.etal.“Cow’smilkconsumption,HLA-DQB1genotype,andType1diabetes.”Diabetes49(2000):912–917.

37. MonetiniL.,CavalloM.G.,StefaniniL.etal.“Bovinebeta-caseinantibodiesinbreast-andbottle-fedinfants:theirrelevanceinType1diabetes.”Diabetes Metab. Res. Rev. 17(2001):51–54.

38. NorrisJ.M.andPietropaoloM.“Reviewarticle.Controversialtopicsseries:milkproteinsanddiabetes.”J. Endocrinol. Invest.22(1999):568–580.

39. ReingoldS.C.“ResearchDirectionsinMultipleSclerosis.”NationalMultipleSclerosisSociety,November25,2003.Accessedatwww.nationalmssociety.org/%5CBrochures-Research.asp

40. AckermannA.“DiemultipleskleroseinderSchweiz.”Schweiz.med.Wchnschr.61(1931):1245–1250.

41. SwankR.L.“Multiplesclerosis:correlationofitsincidencewithdietaryfat.”Am. ]. Med. Sci.220(1950):421–430.

42. DipJ.B.“Thedistributionofmultiplesclerosisinrelationtothedairyindustryandmilkconsumption.”New Zealand Med.].83(1976):427–430.

43. McDougall J. M. 2002. Multiple sclerosis stopped by McDougall/SwankProgram.www.nealhendrickson.com/McDougall/McDnewan-nouncementSwank021112.htm.AccessedNov.16,2002.

44. McLeodJ.G.,HammondS.R.andHallpikeJ.E.“EpidemiologyofmultiplesclerosisinAustralia.WithNSWandSAsurveyresults.”Med. J. Austr. 160(1994):117–122.

45. LawrenceJ.S.,BehrendT.,BennettP.H.etal.“Geographicalstudiesofrheumatoidarthritis.”Ann. Rheum. Dis. 25(1966):425–432.

46. KeenH.andEkoeJ.M.“Thegeographyofdiabetesmellitus.”Brit. Med. Journ.40(1984):359–365.

47. SwankR.L.“Effectoflowsaturatedfatdietinearlyandlatecasesofmultiplesclerosis.”Lancet336(1990):37–39.

48. SwankR.L.“Treatmentofmultiplesclerosiswithlowfatdiet.”A.M.A. Arch. Neurol. Psychiatry 69(1953):91–103.

49. SwankR.L.andBourdillonR.B.“Multiplesclerosis:assessmentoftreatmentwithmodifiedlowfatdiet.”J. Nerv. Ment. Dis.131(1960):468–488.

50. SwankR.L.“Multiplesclerosis:twentyyearsonlowfatdiet.”Arch. Neurol.23(1970):460–474.

51. AgranoffB.W.andGoldbergD.“Dietandthegeographicaldistributionofmultiplesclerosis.”Lancet 2(7888)(November21974):1061–1066.

52. MalosseD.,PerronH.,SascoA.etal.“Correlationbetweenmilkanddairyproductconsumptionandmultiplesclerosisprevalence:aworldwidestudy.”Neuroepidemiology11(1992):304–312.

53. MalosseD.andPerronH.“Correlationanalysisbetweenbovinepopulations,other farm animals, house pets, and multiple sclerosis prevalence.”Neuroepidemiology 12(1993):15–27.

54. LauerK.“Dietandmultiplesclerosis.”Neurology49(Suppl2)(1997):S55–S61.

55. SwankR.L.,LerstadO.,StromA.etal.“MultiplesclerosisinruralNorway.Itsgeographicdistributionandoccupationalincidenceinrelationtonutrition.”New Engl. J. Med. 246(1952):721–728.

56. DalgleishA.G.“Virusesandmultiplesclerosis.”Acta Neurol. Scand. Suppl.

169(1997):8–15.57. McAlpineD.,LumsdenC.E.andAchesonE.D.Multiple sclerosis:

a reappraisal.EdinburghandLondon:E&SLivingston,1965.58. AlterM.,LiebowitzU.andSpeerJ.“Riskofmultiplesclerosisrelatedtoage

atimmigrationtoIsrael.”Arch. Neurol.15(1966):234–237.59. KurtzkeJ.F.,BeebeG.W.andNormanJ.E.,Jr.“Epidemiologyofmultiple

sclerosisinU.S.veterans:1.Race,sex,andgeographicdistribution.”Neurology29(1979):1228–1235.

60. EbersG.C.,BulmanD.E.,SadovnickA.D.etal.“Apopulation-basedstudyofmultiplesclerosis intwins.”New Engl. J. Med.315(1986):1638–1642.

61. AchesonE.D.,BachrachC.A.andWrightF.M.“Somecommentsontherelationshipofthedistributionofmultiplesclerosistolatitudesolarradiationandothervariables.”Acta Psychiatrica Neurologica Scand.35(Suppl147)(1960):132–147.

62. WarrenS.andWarrenK.G.“Multiplesclerosisandassociateddiseases:arelationshiptodiabetesmellitus.”J. Canadian Sci. Neurol. 8(1981):35–39.

63. WertmanE.,ZilberN.,andAbranskyO.“AnassociationbetweenmultiplesclerosisandType1diabetesmellitus.” J. Neurol.239(1992):43–45.

64. MarrosuM.G.,CoccoE.,LaiM.etal.“PatientswithmultiplesclerosisandriskofType1diabetesmellitusinSardinia,Italy:acohortstudy.”Lancet 359(2002):1461–1465.

65. BuzzettiR.,PozzilliP.,DiMarioU.etal.“MultiplesclerosisandType1diabetes.”Diabetologia 45(2002):1735–1736.

66. LuxW.E.andKurtzkeJ.E.“IsParkinson’sdiseaseacquired?Evidencefromageographiccomparisonwithmultiplesclerosis.”Neurology 37(1987):467–471.

67. PrahaladS.,ShearE.S.,ThompsonS.D.etal.“IncreasedPrevalenceofFamilialAutoimmunityinSimplexandMultiplexFamilieswithJuvenileRheumatoidArthritis.”Arthritis Rheumatism 46(2002):1851–1856.

68. CantornaM.T.,MunsickC.,BemissC.etal.“1,25-DihydroxycholecalciferolPreventsandAmelioratesSymptomsofExperimentalMurineInflammatoryBowelDisease.”J. Nutr. 130(2000):2648–2652.

69. CantornaM.T.,WoodwardW.D.,HayesC.E.etal.“1,25-DihydroxyvitaminD3 isapositive regulator for the twoanti-encephalitogeniccytokinesTGF-B1andIL-4.”J Immunol.160(1998):5314–5319.

70. CantornaM.T.,Humpal-WinterJ.andDeLucaH.E.“Dietarycalciumisamajorfactorin1,25-dihydroxycholecalciferolsuppressionofexperimentalautoimmuneencephalomyelitisinmice.”J. Nutr.129(1999):1966–1971.

71. MultipleSclerosisInternationalFederation.“AlternativeTherapies.”November25,2003.Accessedatwww.msif.org/en/symptoms_treatments/treatment_overview/alternative.html

Глава 101. FrassettoL.A.,ToddK.M.,MorrisC.Jr.etal.“Worldwideincidenceofhip

fractureinelderlywomen:relationtoconsumptionofanimalandvegetablefoods.”J. Gerontology55(2000):M585–M592.

2. AbelowB.J.,HolfordT.R.andInsognaK.L.“Cross-culturalassociationbetweendietaryanimalproteinandhipfracture:ahypothesis.”Calcif. Tissue Int. 50(1992):14–18.

3. WachsmanA.andBernsteinD.S.“Dietandosteoporosis.”LancetMay4,1968(1968):958–959.

4. BarzelU.S.“Acidloadingandosteoporosis.”J. Am. Geriatr. Soc. 30(1982):613.

5. ShermanH.C.“Calciumrequirementformaintenanceinman.”J. Biol. Chem.39(1920):21–27.

6. Вживотныхбелкахбольшесеросодержащихаминокислот.Впроцессеперевариванияиметаболизмаэтиаминокислотыгенерируюткислото-образующиесоединениясеры,которыедолжнывыделятьсяорганизмомприпомощипочек.Внедавноопубликованномдокладебылапоказанавпечатляющаякорреляция,равная84%,междуупотреблениемвпищуживотныхбелковивыделениемсеросодержащихкислотсмочой.

7. BrosnanJ.T.andBrosnanM.E.“Dietaryprotein,metabolicacidosis,andcalciumbalance.”In:H.H.Draper(ed.),Advances in Nutritional Research,

pp.77–105.NewYork:PlenumPress,1982.

8. FrassettoL.A.,ToddK.M.,MorrisR.C.,Jr.etal.“Estimationofnet

endogenousnoncarbonicacidproductioninhumansfromdietpotassiumand

proteincontents.”Am. J. Clin. Nutri.68(1998):576–583.

9. MargenS.,ChuJ-Y.,KaufmannN.A.etal.“Studiesincalciummetabolism.

I.Thecalciureticeffectofdietaryprotein.”Am. J. Clin. Nutr.27(1974):

584–589.

10. HegstedM.,SchuetteS.A.,ZemelM.B.etal.“Urinarycalciumandcalcium

balanceinyoungmenasaffectedbylevelofproteinandphosphorusintake.”

J. Nutr. 111(1981):553–562.

11. KerstetterJ.E.andAllenL.H.“Dietaryproteinincreasesurinarycalcium.”

J. Nutr. 120(1990):134–136.

12. WestmanE.C.,YancyW.S.,EdmanJ.S.etal.“CarbohydrateDietProgram.”

Am. J. Med. 113(2002):30–36.

13. SellmeyerD.E.,StoneK.L.,SebastianA.etal.“Ahighratioofdietaryanimal

tovegetableproteinincreasestherateofbonelossandtheriskoffracturein

postmenopausalwomen.”Am. J. Clin. Nutr.73(2001):118–122.

14. HegstedD.M.“Calciumandosteoporosis.”J. Nutr.116(1986):2316–2319.

15. HeaneyR.E.“Proteinintakeandbonehealth:theinfluenceofbeliefsystems

ontheconductofnutritionalscience.”Am.]. Clin. Nutr.73(2001):5–6.

16. CummingsS.R.andBlackD.“Bonemassmeasurementsandriskoffracturein

Caucasianwomen:areviewoffindingsforprospectivestudies.”Am. J. Med.98

(Suppl2A)(1995):2S–24S.

17. MarshallD.,JohnellO.andWedelH.“Meta-analysisofhowwellmeasuresof

bonemineraldensitypredictoccurrenceofosteoporoticfractures.”Brit. Med.

Journ. 312(1996):1254–1259.

18. Lips P. “Epidemiology and predictors of fractures associated with

osteoporosis.”Am. J. Med.103(2A)(1997):3S–11S.

19. LaneN.E.andNevittM.C.“Osteoarthritis,bonemass,andfractures:how

aretheyrelated?”Arthritis Rheumatism46(2002):1–4.

20. LucasF.L.,CauleyJ.A.,StoneR.A.etal.“Bonemineraldensityandriskof

breastcancer:differencesbyfamilyhistoryofbreastcancer.”Am. J. Epidemiol.

148(1998):22–29.

21. CauleyJ.A.,LucasF.L.,KullerL.H.etal.“Bonemineraldensityandrisk

ofbreastcancerinolderwomen:thestudyofosteoporoticfractures.”JAMA

276(1996):1404–1408.22. MinceyB.A.“Osteoporosisinwomenwithbreastcancer.”Curr. Oncol. Rpts.5

(2003):53–57.23. RiisB.J.“Theroleofboneloss.”Am. J. Med.98(Suppl2A)(1995):2S–29S.24. HoS.C.“Bodymeasurements,bonemass,andfractures:doestheEastdiffer

fromtheWest?”Clin. Orthopaed. Related Res.323(1996):75–80.

25. AsprayT.J.,PrenticeA.,ColeT.J.etal.“Lowbonemineralcontentiscommon

butosteoporoticfracturesarerareinelderlyruralGambianwomen.”J. Bone

Min. Res. 11(1996):1019–1025.

26. TsaiK-S.“Osteoporoticfracturerate,bonemineraldensity,andbonemeta-

bolisminTaiwan.”J. Formosan Med. Assoc.96(1997):802–805.

27. WuA.H.,PikeM.C.andStramD.O.“Meta-analysis:dietaryfatintake,

serumestrogenlevels,andtheriskofbreastcancer.”J. Nat. Cancer Inst.

91(1999):529–534.

28. UCLAKidneyStoneTreatmentCenter.“KidneyStones—Index.”March,

1997.Accessedatwww.radsci.ucla.edu:8000/gu/stones/kidneystone.html

29. StamatelouK.K.,FrancisM.E.,JonesC.A.etal.“Timetrendsinreported

prevalenceofkidneystones.”Kidney Int.63(2003):1817–1823.

30. Этагенетическиредкаяразновидностькамнейвпочкахвозникаетврезуль-

татенеспособностипочеккреабсорбцииаминокислотыцистеина.

31. RamelloA.,VitaleC.,andMarangellaM.“Epidemiologyofnephrolothiasis.”

J. Nephrol.13(Suppl3)(2000):S65–S70.

32. RobertsonW.G.,PeacockM.,andHodgkinsonA.“Dietarychangesandthe

incidenceofurinarycalculiintheU.K.between1958and1976.”Chron. Dis.

32(1979):469–476.

33. RobertsonW.G.,PeacockM.,HeyburnP.J.,etal.“Riskfactorsincalcium

stonediseaseoftheurinarytract.”Brit. J. Urology50(1978):449–454.

34. RobertsonW.G.“Epidemiologicalriskfactorsincalciumstonedisease.”

Scand.J. Urol. Nephrol. Suppl53(1980):15–30.

35. RobertsonW.G.,PeacockM.,HeyburnP.J,etal.“Shouldrecurrentcalcium

oxalatestoneformersbecomevegetarians?”Brit.]. Urology51(1979):

427–431.

36. ЭтаинформациябылаозвученанасеминаредоктораРобертсонавТо-

ронто.

37. RobertsonW.G.“Dietandcalciumstones.”Miner Electrolyte Metab.13

(1987):228–234.

38. CaoL.C.,BoeveE.R.,deBruijnW.C.etal.“Areviewofnewconceptsinrenal

stoneresearch.”Scanning Microscopy7(1993):1049–1065.

39. FriedmanD.S.,CongdonN.,KempenJ.etal.“VisionproblemsintheU.S.:

prevalenceofadultvisionimpairmentandage-relatedeyediseaseinAmerica.”

Bethesda,MD:PreventBlindnessinAmerica.NationalEyeInstitute,2002.

40. FooteC.S.Photosensitized oxidation and singlet oxygen: consequences in

biological systems. Vol.2NewYork:AcademicPress,1976.

41. SeddonJ.M.,AjaniU.A.,SperdutoR.D.etal.“Dietarycarotenoids,

vitaminsA,C,andE,andadvancedage-relatedmaculardegeneration.”

JAMA272(1994):1413–1420.

42. EyeDiseaseCase-ControlStudyGroup.“Antioxidantstatusandneovascular

age-relatedmaculardegeneration.”Arch. Ophthalmol.111(1993):104–109.

43. Приупотреблениидругихчетырехгрупппродуктовпитания:брокколи,

моркови,бататаикрупноплоднойтыквы–уменьшениечастотызабо-

леваниясоставляло53,28,33и44%соответственно.Длякаждогоиз

этихпоказателейуменьшениякорреляциялишьприближаласькстати-

стическизначимойилиимеламинимальнуюстатистическуюзначимость.

44. BermanE.R.Biochemistryoftheeye.(Perspectives in vision research).New

York,N.Y:PlenumPublishingCorporation,1991.

45. LyleB.J.,Mares-PerlmanJ.A.,KleinB.E.K.etal.“AntioxidantIntakeand

RiskofIncidentAge-relatedNuclearCataractsintheBeaverDamEyeStudy.”

Am. J. Epidemiol.149(1999):801–809.

46. BatesC.J.,ChenS.J.,MacdonaldA.,etal.“Quantitationofvitamin

Eandacarotenoidpigmentincataracteroushumanlenses,andtheeffect

ofadietarysupplement.”Int. J. Vitam. Nutr. Res.66(1996):316–321.

47. VarmaS.D.,BeachyN.A.andRichardsR.D.“Photoperoxidationoflens

lipids:preventionbyvitaminE.”Photochem. Photobiol.36(1982):623–626.

48. TalanJ.“Alzheimer’sdiagnosescanbetwoyearslate.”Ithaca Journal:8A.

49. PetersenR.C.,SmithG.E.,WaringS.C.etal.“Mildcognitiveimpairment.”

Arch. Neurol.56(1999):303–308.

50. KivipeltoM.,HelkalaE-L.,HanninenT.etal.“Midlifevascularriskfactorsand

late-lifemildcognitiveimpairment.Apopulationbasedstudy.”Neurology56

(2001):1683–1689.

51. BretelerM.M.B.,ClausJ.J.,GrobbeeD.E.etal.“Cardiovasculardisease

anddistributionofcognitivefunctioninelderlypeople:theRotterdamStudy.”

Brit. Med. Journ.308(1994):1604–1608.

52. HaanM.N.,ShemanskiL.,JagustW.J.etal.“TheroleofAPOEe4in

modulatingeffectsofotherriskfactorsforcognitivedeclineinelderlyper-

sons.”JAMA 282(1999):40–46.

53. SparksD.L.,MartinT.A.,GrossD.R.etal.“Linkbetweenheartdisease,

cholesterol,andAlzheimer’sDisease:areview.”Microscopy Res. Tech.50

(2000):287–290.

54. SlooterA.J.,TangM.X.,vanDuijnC.M.etal.“ApolipoproteinEe4andrisk

ofdementiawithstroke.Apopulationbasedinvestigation.”JAMA277(1997):

818–821.

55. MessierC.andGagnonM.“Glucoseregulationandcognitivefunctions:

relationtoAlzheimer’sdiseaseanddiabetes.”Behav. Brain Res.75(1996):

1–11.

56. OttA.,StolkR.P.,HofmanA.etal.“Associationofdiabetesmellitusand

dementia:theRotterdamStudy.”Diabetologia 39(1996):1392–1397.

57. KannelW.B.,WolfP.A.,VerterJ.etal.“Epidemiologicassessmentoftherole

ofbloodpressureinstroke.”JAMA214(1970):301–310.

58. LaunerL.J.,MasakiK.,PetrovitchH.etal.“Theassociationbetweenmidlife

bloodpressurelevelsandlate-lifecognitivefunction.”JAMA 274(1995):

1846–1851.

59. WhiteL.,PetrovitchH.,RossG.W,MasakiK.H.,AbbottR.D.,TengE.L.,

RodriquezB.L.,BlanchetteP.L.,HavlikR.,WergowskeG.,ChiuD.,Foley

D.J.,MurdaughC.andCurbJ.D.“PrevalenceofdementiainolderJapanese-

AmericanmeninHawaii.TheHomolulu-AsiaAgingStudy.”JAMA,276:

955–960,1996.

60. HendrieH.C.,OgunniyiA.,HallK.S.etal.“Incidenceofdementiaand

AlzheimerDiseasein2communities:YorubaresidinginIbadan,Nigeria

andAfricanAmericansresidinginIndianapolis,Indiana.”JAMA285(2001):

739–747.

61. ChandraV.,PandavR.,DodgeH.H.etal.“IncidenceofAlzheimer’sdisease

inaruralcommunityinIndia:theIndo-U.S.Study.”Neurology57(2001):

985–989.

62. Grant W. B. “Dietary links to Alzheimer’s Disease: 1999 Update.”

J.Alzheimer’sDis1(1999):197–201.

63. GrantW.B.“IncidenceofdementiaandAlzheimerdiseaseinNigeriaandthe

UnitedStates.”JAMA 285(2001):2448.

64. Этоисследованиеинтереснее,чемдругие,посколькууровеньвитаминаЕ

измерялсяболееточнымспособомсучетомтогофакта,чтовитаминЕ

переноситсяжиромкрови.ТоестьвысокийуровеньвитаминаЕвкрови

можетиногдабытьобусловленвысокимуровнемжиракрови.

65. ВлияниевитаминаСиселенависследованииПеркинса,согласноавторам,

небылостатистическизначимымврегрессионнойлогистическоймодели.

Янесогласенсихвыводом,посколькуобратнаязависимостьмеждудозой

иреакцией(высокийуровеньантиоксидантоввкрови,уменьшениепоте-

рипамяти)былавпечатляющейиявностатистическизначимой.Авторы

упустилиэтотрезультатвходесвоегоанализа.

66. OrtegaR.M.,RequejoA.M.,AndresP.etal.“Dietaryintakeandcognitive

functioninagroupofelderlypeople.”Am. J. Clin. Nutr.66(1997):803–809.

67. PerrigW.J.,PerrigP.andStahelinH.B.“Therelationbetweenantioxidants

andmemoryperformanceintheoldandveryold.”J. Am. Geriatr. Soc.

45(1997):718–724.

68. GaleC.R.,MartynC.N.andCooperC.“Cognitiveimpairmentandmortality

inacohortofelderlypeople.”Brit. Med. Journ.312(1996):608–611.69. GoodwinJ.S.,GoodwinJ.M.andGarryP.J.“Associationbetweennutritional

statusandcognitive functioninginahealthyelderlypopulation.”JAMA 249(1983):2917–2921.

70. JamaJ.W.,LaunerL.J.,WittemanJ.C.M.etal.“Dietaryantioxidantsandcognitivefunctioninapopulation-basedsampleofolderpersons:theRotterdamStudy.”Am. J. Epidemiol.144(1996):275–280.

71. MartinA.,PriorR.,Shukitt-HaleB.etal.“Effectoffruits,vegetablesorvitaminE-richdietonvitaminsEandCdistributioninperipheralandbraintissues:implicationsforbrainfunction.”J. Gerontology55A(2000):B144–B151.

72. JosephJ.A.,Shukitt-HaleB.,DenisovaN.A.etal.“Reversalsofage-relateddeclinesinneuronalsignaltransduction,cognitive,andmotorbehavioraldeficitswithblueberry,spinach,orstrawberrydietarysupplementation.” J. Neurosci.19(1999):8114–8121.

73. GillmanM.W.,CupplesL.A.,GagnonD.etal.“Protectiveeffectoffruitsandvegetablesondevelopmentofstrokeinmen.”JAMA273(1995):1113–1117.

74. KalmijnS.,LaunerL.J.,OttA.etal.“DietaryfatintakeandtheriskofincidentdementiaintheRotterdamStudy.”Ann. Neurol.42(1997):776–782.

75. Alzheimer’strendwasnotstatisticallysignificant,perhapsduetothesmallnumberofdiseasecases.

76. ClarkeR.,SmithD.,JobstK.A.etal.“Folate,vitaminB12,andserum

totalhomocysteinelevelsinconfirmedAlzheimerdisease.”Arch. Neurol.55(1998):1449–1455.

77. McCullyK.S.“Homocysteinetheoryofarteriosclerosis:developmentandcurrentstatus.” In: A.M.Gotto,Jr.andR.Paoletti(eds.),Athersderosisreviews,Vol.11,pp.157–246.NewYork:RavenPress,1983.

78. Однаковэтойлогикесуществуетподвох.УровеньгомоцистеиначастичнорегулируетсявитаминамигруппыВ,вособенностифолиевойкислотойивитаминомВ

12.Улюдей,испытывающихдефицитэтихвитаминов,уро-веньгомоцистеинаможетбытьвыше.Люди,неупотребляющиепродуктовживотногопроисхождения,подверженырискусниженияуровнявитаминаВ

12ворганизме,и,такимобразом,унихможетбытьвысокийуровеньгомоцистеина.Однако,какописановглаве11,этовбольшейстепенисвязаноснашейоторванностьюотприроды,анеснехваткойпитательных

веществврастительнойдиете.

Часть III1. www.southbeachdiet.com,accessed4/26/04

Глава 111. AtkinsR.C.Dr.Atkins’ New Diet Revolution.NewYork,NY:AvonBooks,

1999.2. TheAlpha-TocopherolBetaCaroteneCancerPreventionStudyGroup.“The

effectofvitaminEandbetacaroteneontheincidenceoflungcancerandothercancersinmalesmokers.”New Engl. J. Med.330(1994):1029–1035.

3. OmennG.S.,GoodmanG.E.,ThornquistM.D.etal.“EffectsofacombinationofbetacaroteneandvitaminAonlungcancerandcardiovasculardisease.”New Engl. ]. Med. 334(1996):1150–1155.

4. U.S.PreventiveServicesTaskForce.“Routinevitaminsupplementationtopreventcancerandcardiovasculardisease:recommendationsandrationale.”Ann. Internal Med.139(2003):51–55.

5. MorrisC.D.andCarsonS.“Routinevitaminsupplementationtopreventcardiovasculardisease:asummaryoftheevidencefortheU.S.PreventiveServicesTaskForce.”Ann. Internal Med.139(2003):56–70.

6. KolataG.“Vitamins:moremaybetoomany(ScienceSection).”The New York Times April29,2003:1,6.

7. U.S.DepartmentofAgriculture.“USDANutrientDatabaseforStandardReference.”Washington,DC:U.S.DepartmentofAgriculture,AgricultureResearchService,2002.Accessedatwww.nal.USDA.gov/fnic/foodcomp

8. HoldenJ.M.,EldridgeA.L.,BeecherG.R.,etal.“CarotenoidcontentofU.S.foods:anupdateofthedatabase.”J. Food Comp. Anal.12(1999):169–196.

9. Точныйсоставпродуктоввэтойбазеданныхбылследующим:сыройговяжийфарш(80%постногомяса/20%жира);свежийсыройсвинойфарш;сыраякурица(бройлерыилицыплятадляжарки),филескожей;сухоецельноемолоко;сыройшпинат;сырыекрасныеспелыепомидоры;зрелыекрупныесеменасыройлимскойфасоли;сыройзеленыйгорошек;

сыройкартофельвмундире.

10. MozafarA.“EnrichmentofsomeB-vitaminsinplantswithapplicationoforganic

fertilizers.”Plant and Soil 167(1994):305–311.

11. BrandD.andSegelkenR.“Largestscientificeffort inCornell’shistory

announced.”Cornell ChronicleMay9,2002.

12. AshrafiK.,ChangF.Y.,WattsJ.L.etal.“Genome-wideRNAianalysisof

Caenorhabitiselegansfatregulatorygenes.”Nature 421(2003):268–272.

13. ShermerM.“Skepticalsayings.Witandwisdomfromskepticspastand

present.”Skeptic9(2002):28.

14. Яникогданебылсторонникомвыделениятакихчеткихмоментовотграниче-

ниястадийинициации,промоцииипрогрессиихроническогозаболевания,

посколькуэтимоментыотсеченияполностьюпроизвольны.Действительно

важнознать,чтоболезньможетприсутствоватьворганизменапротяжении

большейчастинашейжизни,иеслионапрогрессирует,тоэтопроисходит

постепенноинепрерывно.

15. HildenbrandG.L.G.,HildenbrandL.C.,BradfordK.etal.“Five-yearsurvival

ratesofmelanomapatientstreatedbydiettherapyafterthemannerofGerson:

aretrospectivereview.”Alternative Therapies in Health and Medicine1

(1995):29–37.

16. McDougallJ.A.McDougall’s Medicine, A Challenging Second Opinion.

PiscatawayNJ:NewCenturyPublishers,Inc.,1985.

17. SwankR.L.“Multiplesclerosis:twentyyearsonlowfatdiet.”Arch. Neurol.

23(1970):460–474.

18. SwankR.L.“Effectoflowsaturatedfatdietinearlyandlatecasesofmultiple

sclerosis.”Lancet336(1990):37–39.

Часть IV

Глава 13

1. ColenB.D.“TodieinTijuana;astoryoffaith,hopeandlaetrile.”The Washing­

tonPost Magazine,September4,1977:10.

2. BurrosM.“Thesting?America’ssupplementsappetite;scientistsaredubious,butAmerica’sappetiteforfoodsupplementskeepsgrowing.”TheWashington Post August2,1979:El.

3. HilgartnerS.Science on Stage. Expert advice as public drama.Stanford,CA:StanfordUniversityPress,2000.

4. WillettW.“Dietandcancer:oneviewatthestartofthemillennium.”Cancer Epi. Biom. Prey. 10(2001):3–8.

5. BelangerC.F.,HennekensC.H.,RosnerB.etal.“TheNurses’HealthStudy.”Am. J. Nursing(1978):1039–1040.

6. MarchioneM.“Takingthelongview;for25years,Harvard’sNurses’HealthStudyhassoughtanswerstowomen’shealthquestions.”Milwaukee

Journal­Sentinel July16,2001:01G.

7. CarrollK.K.“Experimentalevidenceofdietaryfactorsandhormone-depen-

dentcancers.”Cancer Res.35(1975):3374–3383.

8. ChenJ.,CampbellT.C.,LiJ.etal.Diet,life-styleandmortalityinChina.

Astudyofthecharacteristicsof65Chinesecounties.Oxford,UK;Ithaca,NY;

Beijing,PRC:OxfordUniversityPress;CornellUniversityPress;People’s

MedicalPublishingHouse,1990.

9. HuF.B.,StampferM.J.,MansonJ.E.etal.“Dietaryproteinandriskof

ischemicheartdiseaseinwomen.”Am. Joum. Clin. Nutr.70(1999):221–227.

10. HolmesM.D.,HunterD.J.,ColditzG.A.etal.“Associationofdietaryintake

offatandfattyacidswithriskofbreastcancer.”JAMA281(1999):914–920.

11. U.S.DepartmentofAgriculture.“AgricultureFactBook.”Washington,DC:

U.S.DepartmentofAgriculture,1998.Citedin:InformationPlusNutrition:

a key to good health. Wylie,TX:InformationPlus,1999.

12. Хотясреднийпоказательдолиупотребляемыхкалорий,приходящейся

нажиры,немногоуменьшился,среднееежедневноеупотреблениежиров

(вграммах)осталосьнеизменнымилиувеличилось.

13. InformationPlus.Nutrition: a key to good health.Wylie,TX:Information

Plus,1999.

14. Wegmans.com.01/19/04.Accessedatwww.wegmans.com/recipes

15. Mardiweb.com.“Cheesecake.”01/19/04.Accessedatmardiweb.com/lowfat/dessert.htm#Recipe000857

16. Anonymous.“CentertoCoordinateWomen’sHealthStudy.”Chicago Sun­Times October12.1992:14N.

17. PrenticeR.L.,KakarF.,HurstingS.etal.“AspectsoftherationalefortheWomen’sHealthTrial.”J. Natl. Cancer Inst.80(1988):802–814.

18. HendersonM.M.,KushiL.H.,ThompsonD.J.etal.“Feasibilityofarandomizedtrialofalowfatdietforthepreventionofbreastcancer:dietarycompliance intheWomen’sHealthTrailVanguardStudy.”Prev. Med.19(1990):115–133.

19. SelfS.,PrenticeR.,IversonD.etal.“StatisticaldesignoftheWomen’sHealthTrial.”Controlled Clin. Trials9(1988):119–136.

20. ArmstrongD.,andDollR.“Environmentalfactorsandcancerincidenceandmortalityindifferentcountries,withspecialreferencetodietarypractices.”Int. J. Cancer15(1975):617–631.

21. CampbellT.C.“Thedietarycausesofdegenerativediseases:nutrientsvsfoods.”In:N.J.TempleandD.P.Burkitt(eds.),Western diseases: their dietary prevention and reversibility,pp.119–152.TotowaN.J.:HumanaPress,1994.

22. WhiteE.,ShattuckA.L.,KristalA.R.etal.“Maintenanceofalow-fatdiet:follow-upoftheWomen’sHealthTrial.”Cancer Epi. Biom. Prev1(1992):315–323.

23. WillettW.C.,HunterD.J.,StampferM.J.etal.“Dietaryfatandfiberinrelationtoriskofbreastcancer.An8-yearfollow-up.”J. Am. Med. Assoc.268(1992):2037–2044.

24. WillettW.“Dietaryfatandbreastcancer.”Toxicol.Sri.52(Suppl)(1999):127–146.

25. HunterD.J.,SpiegelmanD.,AdamiH-O.etal.“Cohortstudiesoffatintakeandtheriskofbreastcancer—apooledanalysis.”New Engl.]. Med.334(1996):356–361.

26. MissmerS.A.,Smith-WarnerS.A.,SpiegelmanD.etal.“Meatanddairyconsumptionandbreastcancer:apooledanalysisofcohortstudies.”Int.

J. Epidemiol.31(2002):78–85.

27. RockhillB.,WillettW.C.,HunterD.J.etal.“Physicalactivityandbreast

cancerriskinacohortofyoungwomen.”J. Nat. Cancer Inst.90(1998):

1155–1160.

28. Smith-WarnerS.A.,SpiegelmanD.,AdamiH-O.etal.“Typesofdietary

fatandbreastcancer:apooledanalysisofcohortstudies.” Int. J. Cancer 92

(2001):767–774.

29. HunterD.J.,MorrisJ.S.,StampferM.J.etal.“Aprospectivestudyofselenium

statusandbreastcancerrisk.”JAMA 264(1990):1128–1131.

30. Smith-WarnerS.A.,SpiegelmanD.,YaunS-S.etal.“Intakeoffruitsand

vegetablesandriskofbreastcancer:apooledanalysisofcohortstudies.”JAMA

285(2001):769–776.

31. MukamalK.J.,ConigraveK.M.,MittlemanM.A.etal.“Rolesofdrinking

patternandtypeofalcoholconsumedincoronaryheartdiseaseinmen.”New

Engl. J. Med.348(2003):109–118.

32. TanasescuM.,HuF.B.,WillettW.C.etal.“Alcoholconsumptionandriskof

coronaryheartdiseaseamongmenwithType2diabetesmellitus.”J. Am. Coll.

Cardiol.38(2001):1836–1842.

33. Smith-WarnerS.A.,SpiegelmanD.,YaunS-S.etal.“Alcoholandbreastcancer

inwomen.Apooledanalysisofcohortstudies.”JAMA279(1998):535–540.

34. HeK.,RimmE.B.,MerchantA.etal.“Fishconsumptionandriskofstroke

inmen.”JAMA288(2002):3130–3136.

35. AlbertC.M.,HennekensC.H.,O’DonnellC.J.etal.“Fishconsumptionand

riskofsuddencardiacdeath.”JAMA279(1998):23–28.

36. U.S.DepartmentofAgriculture.“USDANutrientDatabaseforStandard

Reference.”Washington,DC:U.S.DepartmentofAgriculture,Agriculture

ResearchService,2002.Accessedatwww.nal.usda.gov/fnic/foodcomp

37. HuF.B.,StampferM.J.,RimmE.B.etal.“Aprospectivestudyofegg

consumptionandriskofcardiovasculardiseaseinmenandwomen.”JAMA

281(1999):1387–1394.

38. HuF.B.,MansonJ.E.,andWillettW.C.“Typesofdietaryfatandriskof

coronaryheartdisease:acriticalreview.”J. Am. Coll. Nutr.20(2001):5–19.

39. Mitchell S. “Eggs might reduce breast cancer risk.” United Press

International Feb.21,2003.

40. SteinmetzK.A.andPotterJ.D.“Eggconsumptionandcancerofthecolon

andrectum.”Eur. J. Cancer Prev.,3:237–245,1994.

41. GiovannucciE.,RimmE.B.,StampferM.J.,etal.“Intakeoffat,meat,andfiber

inrelationtoriskofcoloncancerinmen.”Cancer Res.54(1994):2390–2397.

42. FuchsC.S.,GiovannucciE.,ColditzG.A.etal.“Dietaryfiberandtherisk

ofcolorectalcancerandadenomainwomen.”New Engl. J. Med.340(1999):

169–176.

43. HigginsonJ.“Presenttrendsincancerepidemiology.”Proc. Can. Cancer

Conf.8(1969):40–75.44. Burkitt D. P. “Epidemiologyof cancer of the colon and the rectum.”

Cancer 28(1971):3–13.45. TrowellH.C.andBurkittD.P.Western diseases: their emergence and

prevention.London:Butler&Tanner,Ltd.,1981.46. BoydN.F.,MartinL.J.,NoffelM.etal.“Ameta-analysisofstudiesofdietary-

fatandbreastcancerrisk.”Brit. J. Cancer68(1993):627–636.47. CampbellT.C.“Animalproteinandischemicheartdisease.”Am. J. Clin. Nutr.

71(2000):849–850.48. HuF.B.,andWillettW.“ReplytoTCCampbell.”Am. J. Clin. Nutr.71(2000):

850.49. MorrisC.D.andCarsonS.“Routinevitaminsupplementationtoprevent

cardiovasculardisease:asummaryoftheevidencefortheU.S.PreventiveServicesTaskForce.”Ann. Internal Med. 139(2003):56–70.

50. U.S.PreventiveServicesTaskForce.“Routinevitaminsupplementationtopreventcancerandcardiovasculardisease:recommendationsandrationale.”Ann. Internal Med.139(2003):51–55.

Глава 141. PutmanJ.J.andAllshouseJ.E.“FoodConsumption,Prices,andExpen-

ditures, 1970–95.” Washington, DC: United States Department of

Agriculture,1997.Citedin:InformationPlus.Nutrition: a key to good health.Wylie,TX:InformationPlus,1999.

2. NationalDairyCouncil.July15,2003.Accessedatwww.nationaldairycouncil.org/aboutus.asp

3. DairyManagementInc.“WhatisDairyManagementInc.?”February12,2004.Accessedatwww.dairycheckoff.com/whatisdmi.htm

4. DairyManagementInc.Pressrelease.“Dairycheckoff2003unifiedmarketingplanbudgetgearedtohelpincreasedemandindomesticandinternationalmarkets.”Rosemont,IL:January24,2003.Accessedatwww.dairycheckoff.com/news/release-012403.asp

5. NationalWatermelonPromotionBoard.January12,2004.Accessedatwww.watermelon.org

6. DairyManagementInc.“2001AnnualReport.”DairyManagement,Inc.,2001.Accessedatwww.dairycheckoff.com/annualreport.htm/

7. UnitedStatesDepartmentofAgriculture.“ReporttoCongressontheNationalDairyPromotionandResearchProgramandtheNationalFluidMilkProcessorPromotionProgram.”2000.Accessedatwww.ams.usda.gov/dairy/prb_intro.htm.IN

8. UnitedStatesDepartmentofAgriculture.“ReporttoCongressontheNationalDairyPromotionandResearchProgramandtheNationalFluidMilkProcessorPromotionProgram.”2003.Accessedatwww.ams.usda.gov/dairy/prb/prb_rept_2003.htm

9. NutritionExplorations.July,2003.Accessedatwww.nutritionexplorations.com10. PowellA.“SchoolofPublicHealthhostsfoodfight:McDonald’s,dairyindustry,

dietaryreformersfaceoffatsymposium.”Harvard Gazette:24October2002.Accessedatwww.news.harvard.edu/gazette/2002/10.24/09-food.html

11. HaY.L.,GrimmN.K.andParizaM.W.“Anticarcinogensfromfriedgroundbeef:heat-alteredderivativesof linoleicacid.”Carcinogensis8(1987):1881–1887.

12. HaY.L.,StorksonJ.andParizaM.W.“Inhibitionofbenzo(a)pyrene-inducedmouseforestomachneoplasiabyconjugateddenoicderivativesoflinoleicacid.”

Cancer Res.50(1990):1097–1101.

13. AydinR.,ParizaM.W.,andCookM.E.“Oliveoilpreventstheadverseeffectsofdietaryconjugatedlinoleicacidonchickhatchabilityandeggquality.”J. Nutr. 131(2001):800–806.

14. PetersJ.M.,ParkY.,GonzalezF.J.etal.“Influenceofconjugatedlinoleicacidonbodycompositionandtargetgeneexpressioninperoxisomeproliferator-activatedreceptoralpha-nullmice.”Biochim. Biophys.Acta1533(2001):233–242.

15. NtambiJ.M.,ChoiY.,ParkY.etal.“Effectofconjugatedlinoleicacid(CLA)onimmuneresponses,bodycompositionandstearoyl-CoAdesaturase.”Can. J. Appl. Physiol.27(2002):617–627.

16. IpC.,ChinS.F.,ScimecaJ.A.etal.“Mammarycancerpreventionbyconjugateddienoicderivativeof linoleicacid.”Cancer Res.51(1991):6118–6124.

17. IpC.,ChengJ.,ThompsonH.J.etal.“Retentionofconjugatedlinoleicacidinthemammaryglandisassociatedwithtumorinhibitionduringthepost-initiationphaseofcarcinogenesis.”Carcinogensis 18(1997):755–759.

18. YaukeyJ.“Changingcows’dietselevatesmilks’cancer-fighting.”Ithaca JournalNovember12,1996:1.

19. BeluryM.A.“Inhibitionofcarcinogenesisbyconjugatedlinoleicacid:potentialmechanismsofaction.”J. Nutr.132(2002):2995–2998.

20. IpC.,BanniS.,AngioniE.etal.“Conjugatedlinoleicacid-enrichedbutterfataltersmammaryglandmorphogenesisandreducescancerriskinrats.”J. Nutr. 129(1999):2135–2142.

21. GriinariJ.M.,CorlB.A.,LacyS.H.etal.“ConjugatedlinoleicacidissynthesizedendogenouslyinlactatingdairycowsbyD9-desaturase.”J. Nutr.130(2000):2285–2291.

22. IpC.,DongY.,ThompsonH.J.etal.“Controlofratmammaryepitheliumproliferationbyconjugatedlinoleicacid.”Nutr. Cancer39(2001):233–238.

23. IpC.,DongY.,IpM.M.etal.“Conjugatedlinoleicacid isomersandmammarycancerprevention.”Nutr.Cancer 43(2002):52–58.

24. GiovannucciE.“Insulinandcoloncancer.”Cancer Causes and Control6

(1995):164–179.

25. MillsP.K.,BeesonW.L.,PhillipsR.L.etal.“Cohortstudyofdiet,lifestyle,

andprostatecancer.”Cancer64(1989):598–604.

26. Searchforkeyword“lycopene”atwww.ncbi.nlm.nih.gov

27. ChristianM.S.,SchulteS.andHellwigJ.“Developmental(embryo-fetal

toxicity/teratogenecity)toxicitystudiesofsyntheticcrystallinelycopeneinrats

andrabbits.”Food Chem. Toxicol.41(2003):773–783.

28. GiovannucciE.,RimmE.,LiuY.etal.“Aprospectivestudyoftomato

products,lycopene,andprostatecancerrisk.”J. Nat. Cancer Inst.94(2002):

391–398.29. GannP.H.andKhachikE.“Tomatoesorlycopeneversusprostatecancer:

isevolutionantireductionist?”J. Nat. Cancer Inst.95(2003):1563–1565.30. TuckerG.“Nutritionalenhancementofplants.”Curr. Opin.14(2003):221–

225.31. HeY.Effects of carotenoids and dietary carotenoid extracts on aflatoxin

B1­induced mutagenesis and hepatocarcinogenesis.Ithaca,NY:Cornell

University,PhDThesis,1990.32. HeY.andCampbellT.C.“EffectsofcarotenoidsonaflatoxinB1-induced

mutagenesisinS.typhimuriumTA100andTA98.”Nutr. Cancer 13(1990):243–253.

33. GiovannucciE.,AscherioA.,RimmE.B.etal.“Intakeofcarotenoidsandretinolinrelationtoriskofprostatecancer.”J. Nat. Cancer Inst.87(1995):1767–1776.

34. U.S.DepartmentofAgriculture.“USDANutrientDatabaseforStandardReference.”Washington,DC:U.S.DepartmentofAgriculture,AgricultureResearchService,2002.Accessedatwww.nal.usda.gov/fnic/foodcomp

35. EberhardtM.V.,LeeC.Y.andLiuR.H.“Antioxidantactivityoffreshapples.”Nature405(2000):903–904.

Глава 151. AustokerJ.“The’treatmentolchoice’:breastcancersurgery1860–1985.”

Soc. Soc. Hist. Med. Bull. (London)37(1985):100–107.

2. NailehS.W.The Best Doctors in America,1994–1995.Aiken,S.C.:Woodward&White,1994.

3. McDougallJ.A.andMcDougallM.A.The McDougall Plan. Clinton,NJ:NewWinPublishing,Inc.,1983.

4. CommitteeonNutritioninMedicalEducation.“NutritionEducationinU.S.MedicalSchools.”Washington,DC:NationalAcademyolSciences,1985.

5. WhiteP.L.,JohnsonO.C.andKiblerM.J.“CouncilonFoodsandNutrition,AmericanMedicalAssociation—itsrelationtophysicians.”Postgraduate Med.30(1961):502–507.

6. LoC.“Integratingnutritionasathemethroughoutthemedicalschoolcurriculum.”Am.]. Clin. Nutr.72(Suppl)(2000):882S–889S.

7. PearsonT.A.,StoneE.J.,GrundyS.M.etal.“Translationolnutritionscienceintomedicaleducation:theNutritionAcademicAwardProgram.”Am. J. Clin. Nutr. 74(2001):164–170.

8. KasslerW.J.“AppendixF:TestimonyoltheAmericanMedicalStudentAssociation.”Washington,DC:NationalAcademyolSciences,1985.

9. ZeiselS.H.andPlaistedC.S.“CD-ROMslorNutritionEducation.”J. Am. Coll. Nutr.18(1999):287.

10. Даннаяпрограмматакжеспонсироваласьдвумяилитремяавторитетнымиагентствами,нояподозреваю,чторуководствоэтихагентствсочлоне-обходимымобнародоватьсвоюсвязьспроектомвобластимедицинскогообразованиявсвоихсобственныхцелях,непринимаявовниманиесо-мнительныйсписокдругихорганизаций.

11. www.med.unc.edu/nutr/nim/FAQ.htmSanchorl9734312. WeinsierR.L.,BokerJ.R.,BrooksC.M.etal.“Nutritiontrainingingraduate

medical(residency)education:asurveyolselectedtrainingprograms.”Am. J. Clin. Nutr.54(1991):957–962.

13. YoungE.A.“NationalDairyCouncilAwardlorExcellenceinMedical/DentalNutritionEducationLecture,1992:perspectivesonnutritioninmedicaleducation.”Am. J. Clin. Nutr.56(1992):745–751.

14. KushnerR.E.“Willtherebeatippingpointinmedicalnutritioneducation?”Am. ]. Clin. Nutr.77(2003):288–291.

Глава 16

1. MacilwainG.The General Nature and Treatment of Tumors.London,UK:JohnChurchill,1845.

2. WilliamsH.The Ethics of Diet. A Catena of Authorities Deprecatory of the Practice of Flesh­Eating.London:F.Pitman,1883.

3. U.S.CensusBureau.“U.S.PopclockProjection.”March,2004.Accessedatwww.census.gov/cgi-bin/popclock

4. CentersforDiseaseControl.“Prevalenceofadultswithnoknownriskfactorsforcoronaryheartdisease-behavioralriskfactorsurveillancesystem,1992.”Morbidity and mortality weekly report43(February4,1994):61–63,69.

5. KaufmanD.W.,KellyJ.P.,RosenbergL.etal.“RecentpatternsofmedicationuseintheambulatoryadultpopulationoftheUnitedStates:theSlonesurvey.”J. Am. Med. Assoc.287(2002):337–344.

6. FlegalK.M.,CarrollM.D.,OgdenC.L.etal.“PrevalenceandtrendsinobesityamongU.S.adults,1999–2000.”JAMA288(2002):1723–1727.

7. AmericanHeartAssociation.“Highbloodcholesterolandotherlipids—statistics.”March,2004.Accessedatwww.americanheart.org/presenter.jhtml?identifier=2016

8. WolzM.,CutlerJ.,RoccellaE.J.etal.“StatementfromtheNationalHighBloodPressureEducationProgram:prevalenceofhypertension.” Am.]. Hypertens. 13(2000):103–104.

9. LucasJ.W.,SchillerJ.S.andBensonV.“SummaryhealthstatisticsforU.S.Adults:NationalHealthInterviewSurvey,2001.”NationalCenterforHealthStatistics.VitalHealthStat.10(218).2004

10. RobbinsJ.The Food Revolution.Berkeley,California:ConariPress,2001.11. РекомендуюпрочестькнигуДжонаРоббинсаTheFoodRevolution,вко-

торойубедительноиподробнопоказанавзаимосвязьмеждупитаниемиокружающейсредой.

12. World Health Organization. “The World Health Report 1997: Press

Release.Humanandsocialcostsofchronicdiseaseswill riseunless

confrontednow,WHODirector-Generalsays.”Geneva,Switzerland:World

HealthOrganization,1997.Accessedatwww.who.int/whr2001/2001/archives/1997/presse.htm

13. OrnishD.,BrownS.E.,ScherwitzL.W.,BillingsJ.H.,ArmstrongW.X,PortsT.A.,McLanahanS.M.,KirkeeideR.L.,BrandR.J.andGouldK.L.“Canlifestylechangesreversecoronaryheartdisease?”Lancet,336:129–133,1990.

14. EsselstynC.B.,EllisS.G.,MedendorpS.V.andCroweT.D.“Astrategytoarrestandreversecoronaryarterydisease:a5-yearlongitudinalstudyofasinglephysician’spractice.”J. Family Practice,41:560–568,1995.

15. VegetarianResourceGroup.“HowManyVegetariansAreThere?”March,2004.Accessedatwww.vrg.org/journal/vj2003issue3/vj2003issue3poll.htm

16. Herman-CohenV.“Veganrevolution.”Italica Journal(reprintedfromLATimes)Aug11,2003:12A.

Приложение A

1. BoydJ.N.,MisslbeckN.,ParkerR.S.etal.“SucroseenhancedemergenceofaflatoxinB1(AFB1)-inducedGGtpositiverathepaticcellfoci.”Fed. Proc.41(1982):356Abst.

2. TannenbaumA.andSilverstoneH.“Nutritioninrelationtocancer.”Adv.

Cancer Res. 1(1953):451–501.3. YoungmanL.D.The growth and development of aflatoxin B1­induced

preneoplastic lesions, tumors, metastasis, and spontaneous tumors as they

are influenced by dietary protein level, type, and intervention.Ithaca,NY:CornellUniversity,Ph.D.Thesis,1990.

4. YoungmanL.D.andCampbellT.C.“InhibitionofaflatoxinB1-inducedgamma-glutamyltranspeptidasepositive(GGT+)hepaticpreneoplasticfociandtumorsbylowproteindiets:evidencethatalteredGGT+fociindicateneoplasticpotential.”Carcinogenesis 13(1992):1607–1613.

5. HorioF.,YoungmanL.D.,BellR.C.etal.“Thermogenesis,low-proteindiets,anddecreaseddevelopmentofAFBl-inducedpreneoplasticfociinratliver.”

Nutr. Cancer 16(1991):31–41.

6. BellR.C.,LevitskyD.A.andCampbellT.C.“Enhancedthermogenesis

andreducedgrowthratesdonotinhibitGGT+hepaticpreneoplasticfoci

development.”FASFB].6(1992):1395Abs.

7. MillerD.S.,andPayneP.R.“Weightmaintenanceandfoodintake.”J. Nutr.

78(1962):255–262.

8. StirlingJ.L.andStockM.J.“Metabolicoriginsofthermogenesisbydiet.”

Nature220(1968):801–801.

9. DonaldP.,PittsG.C.andPohlS.L.“Bodyweightandcompositioninlaboratory

rats:effectsofdietswithhighorlowproteinconcentrations.”Science211

(1981):185–186.

10. RothwellN.J.,StockM.J.andTyzbirR.S.“Mechanismsofthermogenesis

inducedbylowproteindiets.”Metabolism32(1983):257–261.

11. RothwellN.J.andStockM.J.“Influenceofcarbohydrateandfatintakeon

diet-inducedthermogenesisandbrownfatactivityinratsfedlowproteindiets.”

J Nutr 117(1987):1721–1726.

12. KriegerE.,YoungmanL.D.andCampbellT.C.“Themodulationofaflatoxin

(AFBl)inducedpreneoplasticlesionsbydietaryproteinandvoluntaryexercise

inFischer344rats.”FASFB].2(1988):3304Abs.

Приложение Б

1. ChenJ.,CampbellT.C.,LiJ.etal.Diet, life­style and mortality in China.

A study of the character istics of 65 Chinese counties.Oxford,UK;Ithaca,

NY;Beijing,PRC:OxfordUniversityPress;CornellUniversityPress;People’s

MedicalPublishingHouse,1990.

2. Имелисьданныепо82заболеваниям,приводящимксмерти,нооколо

третиэтихслучаевбылиповторениемоднойитойжеболезниулюдей

разноговозраста.

3. Этотакжеговоритополученииоченьнебольшогоколичестваполезной

информацииилиополномотсутствиитаковойприучетепоказателейвсех

жителейокруга.Существуетлишьодинпоказательчастотывстречаемости

заболеваниявкаждомокруге;такимобразом,необходимоиметьлишьодин

показательдлялюбойпеременной,используемойдлясравненияспоказа-

телемчастотывозникновенияболезни.

4. PiazzaA.Food consumption and nutritional status in the People’s Republic

of China. London:WestviewPress,1986.

5. MessinaM.andMessinaV.The Dietitians Guide to Vegetarian Diets. Issues

and Applications.Gaithersburg,MD:AspenPublishers,Inc.,1996.

Приложение В1. HolickM.E. In:M.E.Shils,J.A.Olson,M.Shikeande.al(eds.),Modern

nutritioninhealthanddisease,9thed.,pp.329–345.Baltimore,MD:Williams

andWilkins,1999.

2. Barger-LuxM.J.,HeaneyR.,DowellS.etal.“VitaminDanditsmajormeta-

bolites:serumlevelsaftergradedoraldosinginhealthymen.”Osteoporosis

Int.8(1998):222–230.

3. ПериодполувыделенияизорганизмавитаминаDcоставляет10–19дней;

именнотакоевремятребуетсядляисчезновенияполовиныегоколичества.

4. ColstonK.W.,BergerU.andCoombesR.C.“PossibleroleforvitaminDin

controllingbreastcancercellproliferation.”Lancet1(1989):188–191.5. NievesJ.,CosmanF,.HerbertJ.etal.“HighprevalenceofvitaminDdefi-

ciencyandreducedbonemassinmultiplesclerosis.”Neurology44(1994):1687–1692.

6. Al-QadrehA.,VoskakiI.,KassiouC.etal.“Treatmentofosteopeniainchildrenwithinsulin-dependentdiabetesmellitus:theeffectof1-alphahydroxyvitaminD3.”Eur. ]. Pediatr. 155(1996):15–17.

7. CantornaM.T.,HayesC.E.andDeLucaH.E.“1,25-DihydroxyvitaminD3reversiblyblockstheprogressionofrelapsingencephalomyelitis,amodelofmultiplesclerosis.”Proc. National Acad.Sci93(1996):7861–7864.

8. RozenF.,YangX-F.,HuynhH.etal.“AntiproliferativeactionofvitaminD-relatedcompoundsand insulin-likegrowth factor-bindingprotein5accumulation.”J. Nat. Cancer Inst.89(1997):652–656.

9. CosmanF.,NievesJ.,KomarL.etal.“Fracturehistoryandbonelossinpa-tientswithMS.”Neurology51(1998):1161–1165.

10. GiovannucciE.,RimmE.,WolkA.etal.“Calciumandfructoseintakeinrelationtoriskofprostatecancer.”Cancer Res.58(1998):442–447.

11. PeehlD.M.,KrishnanA.V.andFeldmanD.“Pathwaysmediatingthegrowth-inhibitoryactionofvitaminDinprostatecancer.”J. Nutr.133(Suppl)(2003):2461S–2469S.

12. ZellaJ.B.,McCaryL.C.andDeLucaH.E.“Oraladministrationof1,25-dihydroxyvitaminD

3completelyprotectsNODmicefrominsulin-dependentdiabetesmellitus.”Arch. Biochem Biophys.417(2003):77–80.

13. DavenportC.B.“Multiplesclerosis fromthestandpointofgeographicdistributionandrace.”Arch. Neurol. Pschiatry8(1922):51–58.

14. AlterM.,YamoorM.andHarsheM.“Multiplesclerosisandnutrition.”Arch. Neurol. 31(1974):267–272.

15. VanderMeiI.A.,PonsonbyA.L.,BlizzardL.etal.“RegionalvariationinmultiplesclerosisprevalenceinAustraliaanditsassociationwithambivalentultravioletradiaion.”Neuroepidemiology20(2001):168–174.

16. McLeodJ.G.,HammondS.R.andHallpikeJ.E.“EpidemiologyofmultiplesclerosisinAustralia.WithNSWandSAsurveyresults.”Med. J. Austr

160(1994):117–122.17. HolickM.E.“VitaminD:amilleniumperspective.”J. Cell. Biochem.

88(2003):296–307.18. MacLaughlinJ.A.,GangeW.,TaylorD.etal.“Culturedpsoriaticfibroblasts

frominvolvedanduninvolvedsiteshaveapartial,butnotabsoluteresistancetotheproliferation-inhibtionactivityof1,25-dihydroxyvitaminD.”Proc. National

Acad. Sci 52(1985):5409–5412.19. GoldbergP.,FlemingM.C.andPicardE.H.“Multiplesclerosis:decreased

relapseratethroughdietarysupplementationwithcalcium,magnesiumandvitaminD.”Med. Hypoth. 21(1986):193–200.

20. AndjelkovicZ.,VojinovicJ.,PejnovicN.etal.“Diseasemodifyingandimmunomodulatoryeffectsofhighdosela(OH)D3inrheumatoidarthritis

patients.”Clin. Exp. Rheumatol.17(1999):453–456.

21. HypponenE.,LaaraE.,ReunanenA.etal.“IntakeofvitaminDandriskofType1diabetes:abirth-cohortstudy.”Lancet358(2001):1500–1503.

22. BreslauN.A.,BrinkleyL.,HillK.D.etal.“Relationshipofanimalprotein-richdiettokidneystoneformationandcalciummetabolism.”J. Clin. Endocrinol. Metab. 66(1988):140–146.

23. LangmanC.B.“Calcitriolmetabolismduringchronicmetabolicacidosis.”Semin. Nephrol.9(1989):65–71.

24. ChanJ.M.,GiovannucciE.L.,AnderssonS-O.etal.“Dairyproducts,calcium,phosphorus,vitaminD,andriskofprostatecancer(Sweden).”Cancer Causes and Control9(1998):559–566.

25. ByrneP.M.,FreaneyR.andMcKennaM.J.“VitaminDsupplementationintheelderly:reviewofsafetyandeffectivenessofdifferentregimes.”Calcified Tissue Int. 56(1995):518–520.

26. AgranoffB.W.andGoldbergD.“Dietandthegeographicaldistributionofmultiplesclerosis.”Lancet2(7888)(November21974):1061–1066.

27. AkerblomH.K.,VaaralaO.,HyotyH.etal.“EnvironmentalfactorsintheetiologyofType1diabetes.”Am.]. Med. Genet.(Semin. Med. Genet.) 115(2002):18–29.

28. ChanJ.M.,StampferM.J.,MaJ.etal.“Insulin-likegrowthfactor-I(IGF-I)andIGFbindingprotein-3aspredictorsofadvanced-stageprostatecancer.”J Natl Cancer Inst94(2002):1099–1109.

29. CohenP.,PeehlD.M.,andRosenfeldR.G.“TheIGFaxisintheprostate.”Horm. Metab. res.26(1994):81–84.

30. DoiS.Q.,RasaiahS.,TackI.etal.“Low-proteindietsuppressesseruminsulin-likegrowthfactor-1anddeceleratestheprogresseionofgrowthhormone-inducedglomerulosclerosis.”Am. J. Nephrol. 21(2001):331–339.

31. HeaneyR.P.,McCarronD.A.,Dawson-HughesB.etal.“Dietarychangesfavorablyaffectbondremodeling inolderadults.”J. Am. Diet. Assoc. 99(1999):1228–1233.

32. AllenN.E.,ApplebyP.N.,DaveyG.K.etal.“Hormonesanddiet:lowinsulin-likegrowthfactor-Ibutnormalbioavailableandrogensinveganmen.”Brit. J. Cancer83(2000):95–97.